10-K 1 cca1130201410k.htm 10-K CCA 11.30.2014 10K
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
 
FORM 10-K
 
 
 
Annual Report Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
For the Fiscal Year Ended November 30, 2014
Commission File Number 001-31643 
 
CCA INDUSTRIES, INC.
(Exact Name of Registrant as specified in Charter)
  
 
 
DELAWARE
 
04-2795439
(State or other jurisdiction of
incorporation or organization)
 
(I.R.S. Employer
Identification No.)
200 Murray Hill Parkway, East Rutherford, New Jersey 07073
(Address of principal executive offices, including zip code)
(201) 935-3232
(Registrant’s telephone number, including area code)
Securities registered pursuant to Section 12(b) of the Act: 
 
 
 
Title of class
 
Name of each exchange on which registered
Common Stock, par value $0.01 per share
 
New York Stock Exchange: MKT
Class A Common Stock, par value $0.01 per share
 
New York Stock Exchange: MKT
Securities registered pursuant to Section 12(g) of the Act: NONE  
 
Indicate by check mark if the Registrant is a well-known seasoned issuer, as defined in Rule 405 of The Securities Act.     Yes  ¨    No  ý
Indicate by check mark if the Registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.     Yes  ¨    No  ý
Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15 (d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirement for the past 90 days.     Yes  ý    No  ¨
Indicate by check mark whether the Registrant has submitted electronically and posted on its corporate website, if any, every interactive data file required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding twelve months (or for such shorter period that the Registrant was required to submit and post such files. Yes  ý    No  ¨



Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained herein, and will not be contained, to the best of Registrant’s knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K. ¨
Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company. See the definitions of “large accelerated filer”, “accelerated filer”, “non-accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. 
 
 
 
 
 
 
 
Large accelerated filer
 
o
  
Accelerated filer
 
o
 
 
 
 
Non-accelerated filer
 
o
  
Smaller reporting company
 
ý
Indicate by check mark whether the Registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).     Yes  ¨  No  ý
The aggregate market value of the voting stock held by non-affiliates of the Registrant (i.e., by persons other than officers and directors of the Registrant and holders of 10% or more of the Registrant’s voting stock), at the closing sales price of $3.20 on May 31, 2014, was as follows: 
 
 
 
Class of Voting Stock
Market Value
5,266,710
shares; Common Stock, $.01 par value
$16,853,472
On February 21, 2015 there were 6,038,982 shares of Common Stock and 967,702 shares of Class A Common Stock of the Registrant outstanding.
 









TABLE OF CONTENTS
 
 
 
 
Page
Number
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 



PART I
Cautionary Statements Regarding Forward-Looking Statements

Our disclosure and analysis in this report contains forward-looking information that involves risks and uncertainties. Our forward-looking statements express our current expectations or forecasts of possible future results or events, including projections of future performance, liquidity, statements of management’s plans and objectives, future contracts, and forecasts of trends and other matters, and you can identify these statements by the fact that they do not relate strictly to historic or current facts and often use words such as “anticipate”, “estimate”, “expect”, “believe”, “will”, “will likely result”, “plan”, “should”, “outlook”, “plan” “project” and other words and expressions of similar meaning. We can give no assurance that such expectations or forward-looking statements will prove to be correct. An occurrence of or any material adverse change in one or more of the risk factors or risks and uncertainties referred to in this report or included in our other public disclosures or our other periodic reports or other documents or filings filed with or furnished to the SEC could materially and adversely affect our continuing operations and our future financial results, cash flows, available credit, prospects and liquidity. Forward-looking statements speak only as of the date of this filing, and we undertake no obligation to update or revise such statements to reflect new circumstances or unanticipated events or other circumstances affecting such forward-looking statements occurring after the date of this report, even if such results, changes or circumstances make it clear that any forward-looking information will not be realized. Any public statements or disclosures by us following this report which modify or impact any of the forward-looking statements contained in this report will be deemed to modify or supersede such statements in this report. No assurance can be given that the results in any forward-looking statement will be achieved and actual results could be affected by one or more factors, which could cause actual results to differ materially from such forward-looking statements. Factors that may cause actual results to differ materially from those contemplated by such forward-looking statements include those risk factors listed under the “Risk Factors” section of this Annual Report on Form 10-K and other risks and uncertainties identified below.

All of the information concerning our future liquidity, future net sales, margins and other future financial performance and results, achievement of operating plan or forecasts for future periods, sources and availability of credit and liquidity, future cash flows and cash needs, success and results of strategic and operating initiatives, anticipated cost savings and other reduced spending, and other future financial performance or financial position, as well as our assumptions underlying such information, constitute forward-looking information. Our forward-looking statements are based on a series of expectations, assumptions, estimates and projections about the Company, are not guarantees of future results or performance and involve substantial risks and uncertainty, including assumptions and projections concerning our internal operating plan, operating cash flows, liquidity and sources and availability of credit for all forward periods. Our business and our forward-looking statements involve substantial known and unknown risks and uncertainties, including the following risks and uncertainties:
the risks associated with our efforts to successfully implement, adjust as appropriate and achieve the benefits of our current strategic initiatives including our outsourcing and restructuring plans and any other future initiatives that we may undertake;
the ability to achieve our operating plan for net sales, working capital and cash flows for fiscal 2015 and 2016;
the ability to access on satisfactory terms, or at all, adequate financing and other sources of liquidity, as and when necessary, to fund our continuing operations, working capital needs, strategic, operating and restructuring initiatives and other cash needs, to obtain an continuation of our credit arrangements with our lender, and to obtain other or additional credit facilities or other internal or external liquidity sources if cash flows from operations and external capital resources are not sufficient for our cash requirements at any time or times;
the satisfaction of all borrowing conditions under our term loan and line of credit, including accuracy of all representations and warranties, no defaults or events of default, absence of material adverse effect or change and all other borrowing conditions, and sufficiency of borrowing base;
    the risks associated with our efforts to maintain our customers and expand to attract new customers;    
the ability to reduce costs and achieve anticipated cost savings;
continued credit from vendors at existing future expected levels and with acceptable payment terms;
    the ability to attract and retain talented and experienced executives that are necessary to execute our initiatives;
the ability to accurately estimate and forecast future selling and other future financial results and financial position;

1


any impact to or disruption in our supply of merchandise;
the ability to reduce spending as needed.
The cautionary statements made in this Annual Report on Form 10-K should be read as being applicable to all forward-looking statements whenever they appear in this Annual Report. For these statements, we claim the protection of the safe harbor for forward-looking statements contained in the Private Securities Litigation Reform Act. In addition to the information set forth in this report, you should carefully consider the risk factors and risks and uncertainties included in this report and other periodic reports filed with the SEC.

Item 1. BUSINESS
(a) 2014 Actions
In December of 2013 CCA Management secured Board approval to its plan to restore profitable growth and deliver sustained shareholder value. To realize its overarching goals, management moved determinedly to: (i) an outsourcing and variable cost- business platform, (ii) reducing overhead expenses measurably, (iii) recapitalizing its business and, (iv) concentrating marketing and advertising efforts against its core business units (Plus White, Sudden Change and Bikini Zone) to enhance and leverage each brands equity power among its unique consumer base.
The following is a summary of key actions that CCA Industries, Inc., (hereafter, “CCA” or the “Company”) took in fiscal 2014 to lay the groundwork for downstream profitable sales growth and fully realize the plan goals:
Outsourcing Arrangements. In January 2014, the Company announced an outsourcing arrangement with The Emerson Group, a premier sales and marketing company located in Wayne, Pennsylvania (“Emerson”), to outsource all warehousing and shipping for domestic accounts and certain sales and administrative functions. In December 2014, the Company entered into a contract with Suite-K Value Added Services, located in New Jersey (“Suite K”), to provide turn key contract manufacturing services for products other than oral care. Warehousing and shipping for international accounts are also being handled by Suite-K. These arrangements are discussed in more detail below in this Item 1.
Loan Agreement and Warrant. On September 5, 2014 (the “Closing Date”), CCA entered into the (i) Loan and Security Agreement (the “Loan Agreement”), and (ii) Warrant to Purchase Common Stock, in each case, with Capital Preservation Solutions, LLC (“Capital Preservation Solutions”). Capital Preservation Solutions is controlled by Lance T. Funston, the Chairman of the Board of Managers of Ultimark Products, LLC, a privately held consumer products company. The Loan Agreement provides for a $5 million line of credit (the “Line of Credit”) and a term loan of $1 million (the “Term Loan” and, together with the Line of Credit, the “Loans”). The proceeds of the Loans are to be used for general working capital purposes. Pursuant to the Loan Agreement, all outstanding amounts of the Loans bear interest at 6% per annum, payable monthly in arrears. The Loans mature on December 5, 2015. The Loans and all other amounts due and owing under the Loan Agreement and related documents are secured by a first priority perfected security interest in, and lien on, substantially all of the assets of the Company. Amounts available for borrowing under the Line of Credit equal the lesser of the Borrowing Base (as defined below), and $5 million, in each case, as the same is reduced by the aggregate principal amount outstanding under the Line of Credit. “Borrowing Base” under the Loan Agreement means, generally, the amount equal to (i) 80% of the Company’s eligible accounts receivable, plus (ii) 50% of the value of eligible inventory, less (iii) certain reserves.
The Loan Agreement otherwise contains customary events of default. Upon the occurrence of an event of default, Capital Preservation Solutions may elect to declare the entire unpaid principal balance of the Loans to be immediately due and payable, together with interest thereon through the date of payment and all costs incurred by and payable to Capital Preservation Solutions under the Loan Agreement. The Loan Agreement contains customary representations, warranties and covenants on the part of the Company. On the Closing Date, in addition to the $1 million in Term Loan proceeds which the Company received, the Company drew $600,000 on the Line of Credit.
In connection with the Loan Agreement, the Company issued the Warrant on the Closing Date, pursuant to which Capital Preservation Solutions has, subject to certain adjustments, the right to purchase from time to time, until September 5, 2019, 1,892,744 shares of Common at a purchase price of $3.17 per share (which represents the NYSE MKT per share closing price of the Common Stock on the day prior to the Closing Date ). The shares underlying the warrant were listed on the NYSE MKT in December 2014. The Warrant may be exercised, at the option of Capital

2


Preservation Solutions, in cash, pursuant to a cashless exercise, or in a combination thereof. The Warrant contains customary antidilution provisions.
Discontinuation of Gel Perfect. The Company discontinued the Gel Perfect color nail polish business effective as of May 31, 2014. The Gel Perfect brand had declining sales in fiscal 2013 and fiscal 2014 to date. Net sales for the year ending November 30, 2014 were $(3,357,104). The negative net sales were due to the large amount of returns received during the period. The Gel Perfect brand is recorded as discontinued operations in our financial statements for fiscal years 2014, 2013, 2012, 2011 and 2010. See note 18 of the consolidated financial statements.
Sale of Mega-T Brand. During the third quarter of fiscal 2014 the Company discontinued its operations of the Mega-T brand of weight loss and dietary supplement business and on August 26, 2014, the Company entered into an asset purchase agreement (“Asset Purchase Agreement”) with Mega-T, LLC (“LLC”), an entity formed by Casla Partners Capital Fund I, LP for the sale of inventory, trademarks and other intellectual property rights related to the Mega-T brand. Under the Asset Purchase Agreement, the Company sold its inventory consisting of finished goods, work-in-process, raw materials and packaging supplies, as well as the related trademarks, domain names and goodwill of the Mega-T brand. LLC assumed all of the liabilities related to returns, co-operative advertising and contract markdowns that occurred prior to the transaction date but have not yet been deducted by the retailers up to a maximum liability of $2,250,000. LLC also assumed liabilities for all outstanding purchase orders as long as it receives the inventory from the vendors and any obligations that arise subsequent to the transaction date that related to LLC’s operations of the Mega-T business. The Company is responsible for paying the vendors for any inventory received by the Company prior to the transaction date. The Company decided to sell the Mega-T brand in order to focus its resources behinds its five remaining core brands. The Mega-T brand is recorded as discontinued operations in our financial statements for fiscal years 2014, 2013, 2012, 2011 and 2010. See note 18 of the consolidated financial statements.
General Marketing/Advertising. In April of 2014 a new media and advertising approach was initiated against three core business units: Plus White, Sudden Change and Bikini Zone. Working media expenditures in fiscal 2014 amounted to $5,198,645, an increase of $2,078,709 versus fiscal 2013. The plan deemed this investment necessary to stimulate the business after the Company's poor fiscal 2013 performance.
(b) General
CCA INDUSTRIES, INC. (hereinafter, “CCA” or the “Company”) was incorporated in Delaware in 1983.
The Company operates in one industry segment, in what may be generally described as fast moving consumer goods, selling numerous products in several health-and-beauty aids over the counter drug and remedies and cosmeceutical categories. All of the Company’s products are manufactured by contract manufacturers, pursuant to the Company’s specifications and formulations.
The Company owns registered trademarks, or exclusive licenses to use registered trademarks, that identify its products by brand-name. Under most of the brand names, the Company markets several different but categorically-related products. The principal brand and trademark names include “Plus+White” (oral health-care products),“Sudden Change” (skin-care products), “Nutra Nail” (nail treatments), “Bikini Zone” (pre and after-shave products), “Hair Off” (depilatories), “Solar Sense” (sun-care products), “Cherry Vanilla” and other Vanilla fragrances (perfumes), “Lobe Wonder” (ear-care product), "Pain Bust*R II" (topical analgesic) and “Scar Zone” (scar diminishing cream).
All Company products are marketed and sold to major drug, food chains, mass merchandisers and wholesale beauty aids distributors throughout the United States. In addition, certain of the Company’s products are sold internationally, through distributors.
The Company recognizes sales at the time its products are shipped to customers. However, while sales are not formally subject to any contract contingency, returns are accepted if it is in the best interests of the Company’s relationship with the customer. The Company thus estimates ‘unit returns’ based upon a review of the market’s recent-historical acceptance of subject products as well as current market-expectations, and calculates its reserves for estimated returns based on the historical returns as a percentage of sales in the five preceding months, adjusting for returns that can be put back into inventory, and a specific reserve based on customer circumstances, (See "Revenue Recognition" in Note 2 of the consolidated financial statements). Of course, there can be no precise going-forward assurance in

3


respect to return rates and gross margins, and a significant increase in the rate of returns could have a materially adverse effect upon the Company’s financial condition and results of operations.
The Company’s net sales in fiscal 2014 were $30,120,299. Gross profits were $16,490,073. International sales accounted for approximately 13.6% of net sales. The Company had a net loss from continuing operations of $2,803,428 and from discontinued operations a net loss of $5,996,041, for a total net loss of $8,799,469 for fiscal 2014. Total shareholders' equity at November 30, 2014 was $9,565,954.
Including the principal members of management (see Item 10. Directors, Executive Officers and Corporate Governance), the Company, at November 30, 2014, had a total of 37 employees in the areas of sales, administrative, creative, marketing, accounting, and operations.
(c) Manufacturing and Shipping
The Company creates and/or oversees formulations and arranges with independent contractors for the manufacture of its products pursuant to Company specifications. During fiscal 2014, the Company had research and development costs of $458,984 as compared to $741,694 in fiscal 2013. Manufacturing and component-supply arrangements are maintained with various manufacturers and suppliers. All orders and other product shipments were delivered from the Company’s own warehouse facilities through fiscal year end 2013. Effective February 1, 2014, all warehousing and shipping for domestic accounts are being handled by The Emerson Group through Ozburn-Hessey Logistics, one of the largest integrated global supply chain management companies in the United States (“OHL”), from OHL's managed facility in Indianapolis, Indiana. This outsourcing arrangement was announced by the Company on January 20, 2014, as part of the Board's approval of management’s plan to restructure the Company’s operations. As part of such plan, the Company entered into a key business partnership with Emerson, a premier sales and marketing company located in Wayne, Pennsylvania, and outsourced to Emerson certain sales and administrative functions. As noted above, warehousing and shipping for domestic accounts was outsourced to Emerson and managed by OHL. Warehousing and shipping for international accounts are being handled by Suite-K Value Added Services.
(d) Marketing
The Company markets its products to major drug, food and mass-merchandise retail chains, warehouse clubs and leading wholesalers, through an in-house sales force of employees and independent sales representatives throughout the United States, and through distributors internationally.
The Company sells its products to approximately 383 accounts, most of which have numerous outlets. Approximately 40,000 stores carry at least one Company product (SKU). During the fiscal year ended November 30, 2014, the Company’s largest customers were Wal-Mart (approximately 47% of net sales), Walgreens (approximately 7%), Target (approximately 6%), Rite Aid (approximately 5%), CVS (approximately 3%), and Dollar General (approximately 2%). The loss of any of these principal customers, or substantial reduction of sales revenues realized from their business, could materially and negatively affect the Company’s earnings.
Most of the Company’s products are not particularly susceptible to seasonal-sales fluctuation. However, retail sales of depilatory, shave and sun-care products customarily peak in the spring and summer months, while fragrance-product sales customarily peak in the Fall and Winter months.
The Company employs brand managers who are responsible for the marketing of CCA’s brands. These managers work with the Company’s personnel and external resources to create media advertising, packaging and point-of-purchase displays.
The Company primarily utilizes national television advertisements to promote its leading brands. On occasion, print and radio advertisements are engaged. In addition, and on a generally continuous basis, store-centered product promotions are co-operatively undertaken with customers.

Each of the Company’s brand-name products is intended to attract a particular demographic segment of the consumer market, and advertising campaigns are directed to the respective market-segments. The Company targets the following demographic segments and utilizes these specific marketing approaches for each of these core brands:

4


Bikini Zone: Designed to help women relieve the bumps, irritation and redness that can accompany hair removal in the bikini area, the brand is targeted primarily to women aged 18-35 years who remove body hair. Sales volume is seasonal with peak volume occurring between Memorial Day and the July 4th holiday as people prepare for outdoor activity and the swimming season. Marketing efforts are concentrated around this peak season and include in-store displays and secondary placement.
Nutra Nail: Designed to help treat women’s problem nails (weak, brittle), the brand is marketed to women aged 18-54 years, who are concerned about the health and appearance of their nails and cuticles. Nail treatments sales volume tends to be steady throughout the year, while sales volume for nail color tends to experience peak volume during summer months. Marketing efforts have traditionally occurred during all seasons for Nutra Nail treatments. Programs focus around driving in-store consumer trial and include displays, secondary placement and promotional coupons throughout the year.
Plus White: Designed to help consumers whiten their teeth and maintain good oral hygiene, the brand is targeted primarily to women aged 18-49 years, and secondarily to men aged 18-39 years who are concerned about the health and appearance of their teeth. Marketing efforts include national television advertising, in-store displays and secondary placement, and in-pack cross-promotional coupons throughout the year.
Sudden Change: Designed to help women look their best by reducing the appearance of these signs of aging: wrinkles, dark circles, and dullness. Sudden Change brand is targeted primarily to women, aged 34 years and older. Marketing efforts include national TV advertising, in-store displays and in-pack cross-promotional coupons.
The Company’s in-house marketing department and some outside advertising agencies are responsible for the creation of its media advertising. Placement is accomplished either directly or through media-service companies.
(e) “Wholly-Owned” Products
The majority of the Company’s sales revenues are from sales of the Company’s “wholly-owned” product lines (i.e., products sold under trademark names owned by the Company, and not subject to any other party’s interest or license), which include principally “Plus+White”, “Sudden Change”, “Bikini Zone”, “Cherry Vanilla”, and “Scar Zone”.
(f) All Products
The Company’s gross sales net of returns by category percentage were: Skin Care 45.9%; Oral Care 32.9%; Nail Care 13.8%; Fragrance 4.7%; Miscellaneous 1.5%; Analgesic 1.0%, and Hair Care 0.2% .

(g) License-Agreements Products
i. Alleghany Pharmacal
In 1986, the Company entered into a license agreement with Alleghany Pharmacal Corporation (the “Alleghany Pharmacal License”). The license agreement, which is for the exclusive rights to Nutra Nail, Hair Off, Properm and IPR-3 was amended in 2011. The Alleghany Pharmacal License agreement, as amended, requires the Company to pay a royalty rate of 2.5% on net sales of said licensed products, and a minimum royalty of $250,000 per annum. The Company incurred the minimum royalty of $250,000 as the royalty earned was $50,124 for Alleghany Pharmacal for the fiscal year ended November 30, 2014.
ii. Solar Sense, Inc.
CCA commenced the marketing of its sun-care products line following a May 1998 License Agreement with Solar Sense, Inc. (the “Solar Sense License”), pursuant to which it acquired the exclusive right to use the trademark names “Solar Sense” and “Kids Sense” and the exclusive right to market mark-associated products. The Solar Sense License requires the Company to pay a royalty of 5% on net sales of said licensed products until $2 million total royalties are paid, at which time the royalty rate will be reduced to 1% for a period of twenty-five years. The Company

5


incurred royalties of $53,706 for Solar Sense, Inc. for the fiscal year ended November 30, 2014. Since the contract inception through November 30, 2014, the Company has paid a total of $851,183 in royalties to Solar Sense, Inc.
iii. Tea-Guard Inc.
On May 18, 2004, the Company entered into a license agreement with Tea-Guard, Inc. to manufacture and distribute Mega -T Green Tea chewing gum and Mega -T Green Tea mints. The license agreement required the Company to pay a royalty of 6% of net sales for the products sold under the license agreement. The license agreement was amended on March 31, 2009, granting the Company a non-exclusive license, with no minimum royalty required. The royalty rate of 6% of net sales will remain unchanged during the term, including any renewal terms, of the amended license agreement until aggregate royalties of $10 million have been paid to Tea-Guard, Inc., at which point the royalty rate becomes 0%. The Company commenced sales of the Mega -T Green Tea Chewing Gum in July 2004. The Company incurred royalties to Tea-Guard, Inc. totaling $10,263 for the fiscal year ended November 30, 2014. Since the contract inception through November 30, 2014, the Company has paid a total of $587,885 in royalties to Tea-Guard, Inc. The Company discontinued its Mega-T gum and mint products effective August 1, 2015.
iv. Continental Quest Corp.
Effective November 3, 2008, the Company entered into an agreement with Continental Quest Corp., to purchase certain United States trademarks and inventory relating to the Pain Bust*R II business for $285,106 paid at closing. In addition, the Company agreed to pay a royalty equal to 2% of net sales of all Pain Bust*R II products, which are topical analgesics, until an aggregate royalty of $1,250,000 is paid, at which time the royalty payments will cease. The Company incurred royalties to Continental Quest Corp. totaling $7,906 for the fiscal year ended November 30, 2014. Since contract inception through November 30, 2014, the Company has paid a total of $72,227 in royalties to Continental Quest Corp.

v. Joann Bradvica
On March 22, 2002, the Company entered into an agreement with Joann Bradvica, granting the Company an exclusive license to manufacture and sell an Earlobe Patch Support for Earrings. The agreement provided for a royalty of 10% of net sales of the licensed product. A new agreement was entered into and effective on June 8, 2009 at the same royalty rate, and provides for a minimum royalty of $40,000 for annual periods beginning July 1, 2009 in order to maintain the license. The royalty rate becomes 0% upon the expiration of the licensor's patent on April 15, 2015. The Company incurred royalties of $44,388 to Joann Bradvica for the fiscal year ended November 30, 2014.
vi. Hand Perfection, LLC
On October 21, 2010, the Company entered into an agreement with Hand Perfection, LLC and Ellen Sirot, granting the Company an exclusive license to manufacture and market a group of skin care creams under the trademark Hand Perfection, Foot Perfection and products utilizing the name “Ellen Sirot”. The agreement provides for a royalty of 7% of net sales of the licensed products. The Company incurred royalties of $15,520 to Hand Perfection, LLC for the fiscal year ended November 30, 2014. The Company terminated its license agreement with Hand Perfection, LLC effective September 11, 2014.
vii. Other Licenses
The Company is not party to any other license agreement that is currently material to its operations.
(h) Trademarks
The Company’s own trademarks and licensed-use trademarks serve to identify its products and proprietary interests. The Company considers these marks to be valuable assets. However, there can be no assurance, as a practical matter, that trademark registration results in marketplace advantages, or that the presumptive rights acquired by registration will necessarily and precisely protect the presumed exclusivity and asset value of the marks.

(i) Competition

6


The market for fast moving consumer goods, in general, is characterized by vigorous competition among producers, many of whom have substantially greater financial, technological and marketing resources than the Company. Major competitors such as Revlon, L’Oreal, Colgate-Palmolive, Coty, Unilever, and Procter & Gamble have the broadest-based public recognition of their products and are significantly larger than us. Moreover, a substantial number of other health-and-beauty aids manufacturers and distributors may also have greater resources than the Company. In order to successfully compete with larger and better funded brands, the Company employs a strategy of uncovering unmet niche needs within large categories, then developing products specifically designed to address those needs. For example, our Sudden Change Under Eye Firming Serum platform claim is that it can produce a faster result than leading competitive products. Our marketing strategy seeks to employ highly efficient media buying and direct to consumer techniques to create awareness in the most cost efficient manner possible.
(j) Sources and Availability of Raw Materials and Principal Suppliers
The Company does not manufacture any of its products and instead uses contract manufacturers to produce its products. In some cases the Company provides raw materials and packaging materials to the contract manufacturer, and in some cases the contract manufacturer sells the Company a turn-key (complete) product.
The Company entered into a contract with Suite-K Value Added Services on December 16, 2014 to provide turn-key contract manufacturing services for all products other than oral care in order to reduce and control operating costs. The contract states that either party may upon 90 days prior written notice to the other terminate the agreement as of April 1 or October 1 of any year. Under the terms of the agreement, Suite-K is responsible for purchasing the raw materials and components that are required to manufacture the products subject to the agreement. The Company will be receiving the first deliveries of product under the Suite-K turn-key contract in February 2015. The Company's other contract manufacturers produce product based on written purchase orders submitted which specify a quantity of product to be produced. If a particular contract manufacturer was unable to continue producing product for the Company, the Company believes that it could change to an alternate supplier, and depending upon the timing and particular circumstances, this change would not adversely impact the Company’s business or operations.
The Company's other contract manufacturers produce product based on written purchase orders submitted which specify a quantity of product to be produced. If a particular contract manufacturer was unable to continue producing product for the Company, the Company believes that it could change to an alternate supplier, and depending upon the timing and particular circumstances, anticipates that such a change would not materially adversely impact the Company’s business or operations.
The Company also does not have a written contract with any of the suppliers of its raw materials. The suppliers of raw materials fulfill orders based on a written purchase order specifying the quantity of raw materials to be supplied. The Company purchases raw materials from a variety of suppliers and is not dependent on any one supplier. The Company believes that the raw materials in its products are commonly available and that there is no material risk as to its ability to obtain future supplies of such materials.

(k) Government Regulation
All of the products that the Company markets are subject or potentially subject to particular regulation by government agencies, such as the U.S. Food and Drug Administration (“FDA”), the Federal Trade Commission, and various state and/or local regulatory bodies. In the event that any future regulations were to require new approval for any in-the-market products, or should require approval for any planned product, the Company would attempt to obtain the necessary approval and/or license, assuming reasonable and sufficient market expectations for the subject product. However, there can be no assurance, that Company efforts in respect of any future regulatory requirements would result in approvals and issuance of licenses. Moreover, if such license-requirement circumstances should arise, delays inherent in any application-and-approval process, as well as any refusal to approve, could have a material adverse effect upon the Company's financial condition and existing operations (i.e. concerning in-the-market products) or planned operations.
(l) Cost and Effects of Compliance with Environmental Laws
The costs and effects of compliance with environmental laws are not material to the Company.
Item 1A. RISK FACTORS

7


Concentration of Risk.
The Company relies on mass merchandisers and major food and drug chains for the sales of its products. The loss of any one of those accounts or substantial reduction of sales revenues realized from their business could have a material negative impact upon our financial condition and results of operations. All of the Company’s products have independent competition and must be able to compete in order to maintain the Company's position on the retail merchandisers’ shelves. (See Business—General, Item 1 (c) Marketing.)
We are Dependent on Independent Contract Manufacturers.
The Company does not manufacture any of its products. All of the products are manufactured for the Company by independent contract manufacturers. There can be no assurance that these independent contract manufacturers will manufacture our products in the time, in accordance with our specifications or at the level of quality expected. There can be no assurance that the failure of a supplier to deliver the products ordered by the Company, when requested, will not cause burdensome delays in the Company’s shipments to its customers. The Company does constantly seek alternative suppliers should a major supplier fail to deliver as contracted. A failure of the Company to ship as ordered by its customers could cause penalties and/or cancellations of our customers’ orders. In addition, an unanticipated need to transition to a new supplier could result in delays that could impact timely distribution of our products. Any of the foregoing events, depending upon the timing and particular circumstances, could have a material adverse impact on our relationships with our customers and our results of operations, financial condition and business.

There is No Assurance That The Business Will Be Able to Operate Profitably.
In fiscal 2014, net sales were $30,120,299 with a net loss from continuing operations of $2,803,428 and a net loss from discontinued operations a loss of $5,996,041, for a total net loss of $8,799,469. There is no assurance that the Company’s products will be successful. During fiscal 2014, the Company discontinued its Gel Perfect nail polish brand and sold its Mega-T dietary supplement brand, and consumer confidence continued to be low, which had a general impact on the industry and retail sales.
We may experience periods of declines in sales, especially during periods of economic downturn, and any material reduction in our sales could have a material adverse impact on our results of operations, financial condition and business.
Additional risk factors for consideration:
We continue to execute our turnaround strategy and there is no assurance that our sales trends and operating results may not take longer to recover than planned, which would impact our future operating results and cash flows.
Our operating plan contemplates improvement in our operating results for 2015 and beyond. We are in a turnaround, our initiatives designed to improve our sales and operating results are still in the early stages which adds challenges and uncertainty, and we incurred a significant operating loss in fiscal 2013 and 2014. There can be no assurance that our past sales trends and operating results may not continue longer than we expect or may take longer to recover than we have planned or that we will achieve our operating plan, which would negatively impact revenues, operating results and cash flows. Our existing credit facility expires on December 5, 2015, unless it is renewed or extended, which we cannot assure. As a result there is no assurance that our cash from operations and credit from external sources will at all times be sufficient for all of our operating requirements and other cash requirements. If this were to occur, we would closely monitor our operating performance and our liquidity and take actions designed to improve our liquidity and mitigate any shortfall and potentially seek other or additional financing and seek to take other actions, although there can be no assurance that any of these actions would be successful or that any such additional liquidity, if needed, would be available or obtainable on sufficient or favorable terms, which would materially and adversely affect our operating results, liquidity, financial position and business.
We depend on our existing credit facility, which expires on December 5, 2015, unless extended or renewed, which we cannot assure.
During 2014 we entered into a Loan and Security Agreement with Capital Preservation Solutions, LLC for a $5,000,000 working capital line of credit and a term loan for working capital purposes not to exceed $1,000,000.

8


This credit agreement is due to expire by its terms on December 5, 2015, unless renewed or extended for a subsequent period, which we cannot assure. If this credit facility is not extended or renewed beyond its current term, we would seek to obtain other credit facilities to replace it. However, we cannot assure that another credit facility would be available or sufficient for our cash needs or, if available, would be on favorable terms. If our existing credit facility, which is secured by all of our material assets, is not extended or renewed or replaced as of its expiration date with another sufficient credit facility, it is likely we may not have sufficient available cash resources to satisfy such outstanding amount in full on its due date, which would have a material and adverse effect on our liquidity, financial position and business.
The Company Could Face Liquidity Pressure and is Dependent on Capital Preservation Solutions, LLC to Provide Liquidity.
On September 5, 2014, the Company entered into a Loan and Security Agreement (the “Agreement”) with Capital Preservation Solutions, LLC (“Capital”) for a $5,000,000 working capital line of credit and a term loan for working capital purposes not to exceed $1,000,000. The line of credit and term loan have an interest rate of 6% and mature on December 5, 2015. The advances made under the Agreement are subject to a borrowing base calculation that includes 80% of the eligible accounts receivable plus 50% of the value of the eligible inventory. All amounts outstanding under the Agreement are secured by a first priority security interest in all of the assets of the Company. As of November 30, 2014, we had $1,000,000 outstanding under the term loan and $600,000 outstanding under the line of credit. Assuming the continuation of this credit facility over at least the next twelve months and assuming the achievement of the expected benefits of the Company’s outsourcing and restructuring plan, the Company does not anticipate that it will experience liquidity problems during fiscal 2015. The Company currently does not have material overdue outstanding balances with any of its vendors.
If Capital fails to provide the Company with funds under the Agreement as required, if our borrowing availability under the line of credit is limited under the borrowing base calculation or if the term loan and line of credit are not extended, the Company could experience liquidity issues and might not be able to pay its obligations on a timely basis. The term loan contains customary events of default, including failing to pay interest or principle amounts when due, if the Company becomes bankrupt or insolvent, the dissolution of the Company and certain other events more fully described in the Loan and Security Agreement filed with the 8-K by the Company on September 11, 2014. Upon the occurrence of an event of default, Capital may elect to declare the entire unpaid principal balance of the term loan and line of credit to be immediately due and payable, together with interest and all costs incurred by Capital under the loan agreement. Our ability to make payments on our indebtedness and to fund planned capital expenditures and development efforts will depend on our ability to achieve the anticipated benefits of our outsourcing and restructuring plan and our ability to generate cash in the future from our operations which cannot be assured. These items, to a certain extent, are dependent upon industry conditions, as well as general economic, financial, competitive, legislative, regulatory and other factors, many of which are beyond our control.
There is no assurance that our term loan or line of credit will be extended or that we will be able to obtain financing or access the capital markets for future debt or refinancing opportunities in a timely manner, or on acceptable terms, or at all. If we are unable to borrow funds, we may be unable to make the capital expenditures necessary for us to compete with our competitors or take advantage of new business opportunities. As a result, the lack of such funding could have a material adverse effect on our business, results of operations and financial condition and our ability to service our indebtedness.
The Company is Dependent on Outsourced Core Function Vendors
In the first quarter of fiscal 2014, management approved and began implementing the Company's outsourcing agreements with the Emerson Group, which includes sales, customer service, accounts receivable collection functions, warehousing and shipping functions. While there are other vendors that provide these services, which could be sought as alternative vendors, any disruption in our sales, shipments, collections or any other core outsourced function, could have a material adverse effect on the Company's financial condition, results of operations and business.
The Fast Moving Consumer Goods Segment is Highly Competitive.
The market for cosmetics and perfumes, and health-and-beauty aids products in general, including patent medicines, is characterized by vigorous competition among producers, many of whom have substantially greater financial, technological and marketing resources than the Company. Major competitors such as Revlon, L’Oreal,

9


Colgate-Palmolive, Coty, Unilever, and Procter & Gamble have the broadest-based public recognition of their products and are significantly larger than the Company. Moreover, a substantial number of other health-and-beauty aids manufacturers and distributors may also have greater resources than the Company and may therefore have the ability to spend more aggressively on research and development, advertising and marketing, and to respond more effectively to changing business and economic conditions. Our inability to successfully compete with our competitors could have a material adverse effect on the Company's financial condition, results of operation and business.
Our Class A Shareholders Retain Control of Board of Directors.
Class A Shareholder, Capital Preservation Holdings, LLC has the right to elect four members to the Board of Directors. Capital Preservation Holdings, LLC is controlled by Lance Funston. Richard Kornhauser, the Company's Chief Executive Officer, and Stephen A. Heit, the Chief Financial Officer, have an ownership interest in Capital Preservation Holdings, LLC. As a result, they are able to exert significant influence over our business. The holders of Common Stock have the right to elect three members to the Board of Directors.

Future Success Depends on Continued Success of the Company’s Current Products and New Product Development.
The Company is not financially as strong as the major companies against whom it competes. The ability to successfully introduce new niche products and increase the growth and profitability of its current and new niche brand products will affect the business and prospects of the future of the Company and this ability is dependent upon the creativity and marketing skills of management and its advisors and business partners.
All of the Company’s product must be in compliance with all FDA and state regulations and all products which are being manufactured for the Company by outside suppliers must conform to the FDA’s Good Manufacturing Practices requirements. It is the Company’s responsibility to ascertain that the suppliers conform with these requirements. Damage could be caused to our reputation and our relationships with our customers and consumers if our products do not comply with such legal requirements, or with consumer expectations, which could result in diminished sales or liability claims, either of which could have a material adverse impact on our results of operations, financial condition and business.
The Company Relies On A Few Large Customers For A Significant Portion Of Its Sales.
In fiscal 2014, Wal-Mart Stores Inc. represented 47.0% of the Company’s net sales. The Company’s five largest customers accounted for 67.3% of the Company’s net sales. The Company has no agreements with any of its customers to stock its products. The Company’s business would suffer materially if it lost Wal-Mart Stores, Inc. as a customer. The loss of any significant reduction in sales to any of the Company’s five top customers could likely have a material adverse effect on the Company’s financial condition and results of operations.
The Price of the Company’s Stock May Be Volatile.
The Company’s stock could fluctuate substantially. There is a limited float of shares tradable. There are factors beyond the Company’s control which may cause the market price of our stock to fluctuate significantly, including but not limited to the volatility of small cap stocks in general, general stock market conditions, and general economic variations. In addition, variations in the Company’s operating revenues and profits and the timing of advertising commitments also may have an effect on the market price of the Company’s stock.

Climate Change Effects.
The Company continues to monitor climate changes for any potential impact on its business. At this time, the Company does not anticipate that any climate change or climate change regulations will have a material impact on its operations or business.
The Company May Experience Interruptions to Its Business Operations Due to Events Beyond Its Control

10


A catastrophic event beyond the Company’s control, such as a natural disaster, health pandemic, cyber attack, adverse weather event or act of terrorism, that results in the destruction or disruption of any of the Company’s critical business systems or operations could harm its ability to conduct normal business operations and its operating results.
We Depend on Key Personnel.
Our employees are key to the growth and success of our business. This depends, in large part, on our ability to attract, retain and motivate qualified personnel, including our executive officers and key management personnel. If we are unable to attract and retain key personnel, our operating results could be adversely affected.
The Future Growth of the Company Depends on an Effective Marketing Program.
An effective marketing program includes media advertising, in-store merchandising and enhancing distribution, co-operative advertising with our retail partners and product promotions that increase product availability, awareness, and help generate increased sales for our customers. Our inability to develop and implement effective advertising campaign, marketing or promotional programs, that will succeed in a difficult economic environment and highly competitive marketplace, could have a material adverse effect on our business.
We Sell to International Accounts.
In fiscal 2014, international sales accounted for approximately 13.6% of our total net sales with shipments to our Canadian distributor accounting for approximately 2.4% of our total net sales. Our international sales expose the Company to additional risks associated with political or regulatory conditions, the dependence on other economies and foreign currency fluctuations which may diminish demand for U.S. goods and subject us to adverse translation impact. A terrorist attack, the threat of a terrorist attack or foreign military operations or other catastrophic event beyond the Company's control could prevent us from shipping to our international accounts. A loss of or material reduction in our international sales would have a material adverse effect on our business.

We Purchase Some Raw Materials or Components from International Suppliers.
Some of the components used in our products are sourced from international suppliers either by the Company directly or through our turn-key supplier, Suite-K. This exposes the Company to an additional risk of increased costs if the foreign currency exchange rates change unfavorably. A terrorist attack, the threat of a terrorist attack or foreign military operations or other catastrophic event beyond the Company's control could prevent the international suppliers from delivering their goods to the Company or Suite-K. The interruption of the supply could have a material adverse effect on our business.
We Have Entered into Employment and Change of Control Agreements that would Require Us to Make Substantial Payments in connection with a Change of Control of the Company.
The Company has entered into Employment Agreements with Stephen A. Heit, the Company's Chief Financial Officer and Elias Ciudad, Executive Vice President - Information Technology (the “Executives”). The Employment Agreements may, in the event of termination of employment under certain circumstances or a change of control of the Company, result in a lump sum payment equal to three times the Executive’s base annual salary and prior year bonus plus other benefits. As a result, if the Company was required to make a substantial payment to the Executives under these agreements, there would be a significant impact on the Company’s cash reserves and earnings. For further information, see Part III, Section 11, Executive Compensation.

Item 1B. UNRESOLVED STAFF COMMENTS
None

Item 2. PROPERTIES

11


The principal executive offices of the Company are located at 200 Murray Hill Parkway, East Rutherford, New Jersey. Under a net lease, the Company occupies approximately 81,000 square feet of space. Approximately 65,119 square feet in such premises is used for warehousing and 15,881 square feet for offices. The annual rental is $493,340 with an annual Consumer Price Index (“CPI”) increase not cumulatively exceeding 30% in any consecutive five year period. The lease expires on May 31, 2022 with a renewal option for an additional five years. The lease requires the Company to pay for additional expenses, referred to as Common Area Maintenance (“CAM”), which includes real estate taxes, common area expense, utility expense, repair and maintenance expense and insurance expense. For the year ended November 30, 2014, CAM expenses were estimated to be $255,301. CAM is estimated to be $206,000 per year for future years.
Item 3. LEGAL PROCEEDINGS
We are involved from time to time in routine legal matters and other claims incidental to our business. We review outstanding claims and proceedings internally and with external counsel as necessary to assess probability and amount of potential loss. These assessments are re-evaluated at each reporting period and as new information becomes available to determine whether a reserve should be established or if any existing reserve should be adjusted. The actual cost of resolving a claim or proceeding ultimately may be substantially different than the amount of the recorded reserve. In the opinion of management, our financial condition, results of operations, and liquidity should not be materially affected by the outcome of such legal proceedings and claims.

Item 4. MINE SAFETY DISCLOSURES
Not applicable.


12


PART II

Item 5. MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED SHAREHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES
The Company’s Common Stock is traded on the New York Stock Exchange MKT under the symbol “CAW”.
The Company’s Class A Common Stock is listed, but not traded, on the New York Stock Exchange MKT.
The range of high and low sales prices of the Company's Common Stock during each quarter of its 2014 and 2013 fiscal years were as follows:
 
Quarter Ended
 
2014
 
2013
February 28 / February 29
 
$3.28—$2.94
 
$4.75—$4.10
May 31
 
$3.27—$3.00
 
$4.38—$3.37
August 31
 
$4.09—$2.92
 
$3.59—$3.20
November 30
 
$3.59—$3.04
 
$3.51—$3.04
The high and low sales prices for the Company’s Common Stock, on February 17, 2015 were $3.50—$3.49 per share.
As of February 17, 2015, there were approximately 127 individual shareholders of record of the Company’s Common Stock. Based on reports of security position listings and the number of proxies requested by brokers in conjunction with the prior year’s annual meeting of stockholders, we believe there are a substantial number of beneficial holders in various street and depository trust accounts, which represent approximately 1,000 additional shareholders.
As of February 17, 2015, there was one individual shareholder of record of the Company’s Class A Common Stock.
The dividend policy is at the discretion of the Board of Directors of the Company and will depend on numerous factors, including earnings, financial requirements and general business conditions. Additionally, the debt instruments to which we are a party impose restrictions that significantly restrict us from making dividends or distributions. We did not pay any dividends in fiscal 2014 and we currently intend to retain all available funds and any future consolidated earnings to fund our operations and the development and growth of our business.
No dividends were declared or paid in 2014.
On March 7, 2013, the Board of Directors of the Company approved a $0.07 per share dividend for the first quarter ending February 28, 2013, payable to all shareholders of record as of March 19, 2013 and was paid on April 19, 2013.
On July 18, 2013, the Board of Directors of the Company approved a $0.07 per share dividend for the second quarter ending May 31, 2013, payable to all shareholders of record as of August 2, 2013 and was paid on September 3, 2013.
Unregistered Sales. During fiscal 2014, we issued the following equity grants to certain executive officers and directors without registration in reliance on an applicable exemption from registration under Section 4(a)(2) and Regulation D of the Securities Act: On February 1, 2014, the Company granted incentive stock options for 100,000 shares of Common Stock to its President and Chief Executive Officer. The options vest in equal 20% increments commencing on October 17, 2014 and for each of the four subsequent anniversaries of such date and expire on January 31, 2019. On October 2, 2014, a total of 27,000 non-qualified stock options were granted to three directors. The options are scheduled to vest on October 2, 2015 and expire on October 1, 2024. On October 16, 2014, the Company granted incentive stock options for 10,000 shares to Gail Perlow, a Company employee. The options vest in equal 20% increments commencing on October 16, 2015, and for each of the four subsequent anniversaries of such date. The options expire on October 15, 2024.

13


Item 6. SELECTED FINANCIAL DATA
  
 
Years Ended November 30,
 
 
2014
 
2013
 
2012
 
2011
 
2010
Statement of Operations:
 
 
 
 
 
 
 
 
 
 
Sales, Net
 
$
30,120,299

 
$
28,763,369

 
$
32,340,314

 
$
32,216,380

 
$
32,515,033

       (Loss) from Continuing Operations
 
(2,803,428
)
 
(3,511,282
)
 
$
(3,065,470
)
 
(2,281,977
)
 
(5,576,070
)
(Loss) Income from Discontinued Operations
 
(5,996,041
)
 
(2,681,966
)
 
3,530,922

 
2,773,675

 
1,911,310

 Net (Loss) Income
 
(8,799,469
)
 
(6,193,248
)
 
465,452

 
491,698

 
(3,664,760
)
(Loss) Earnings Per Share:
 
 
 
 
 
 
 
 
 
 
Basic
 
 
 
 
 
 
 
 
 
 
Continuing Operations
 
$
(0.40
)
 
$
(0.50
)
 
$
(0.43
)
 
$
(0.32
)
 
$
(0.51
)
Discontinued Operations
 
(0.86
)
 
$
(0.38
)
 
$
0.50

 
0.39

 
0.27

Diluted
 
 
 
 
 
 
 
 
 
 
Continuing Operations
 
$
(0.40
)
 
$
(0.50
)
 
$
(0.43
)
 
$
(0.32
)
 
$
(0.51
)
Discontinued Operations
 
$
(0.86
)
 
$
(0.38
)
 
$
0.50

 
$
0.39

 
$
0.27

Weighted Average Number of Shares Outstanding—Basic
 
7,006,684

 
7,037,694

 
7,054,442

 
7,054,442

 
7,054,442

Weighted Average Number of Shares Outstanding—Diluted
 
7,006,684

 
7,037,694

 
7,054,442

 
7,054,442

 
7,054,442

 
 
 
 At November 30,
Balance Sheet Data:
 
2014
 
2013
 
2012
 
2011
 
2010
Working Capital
 
$
900,826

 
$
12,911,553

 
$
22,668,426

 
$
21,557,320

 
$
22,883,292

Total Assets
 
21,732,592

 
26,345,749

 
35,271,109

 
34,905,527

 
36,312,199

Total Liabilities
 
12,166,638

 
9,283,383

 
11,023,133

 
9,297,476

 
9,142,153

Total Shareholders’ Equity
 
9,565,954

 
17,062,366

 
24,247,976

 
25,608,051

 
27,170,046

Cash Dividends Declared per Common Share
 
$

 
$
0.14

 
$
0.28

 
$
0.28

 
$
0.28


Item 7. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
Reference is made to “Item 1A. Risk Factors” and “Cautionary Statements Regarding Forward-Looking Statements” which describe important factors that could cause actual results to differ materially from expectations and non-historical information contained herein. In addition, the following discussion should be read in conjunction with our financial statements and the notes to those statements and other financial information appearing elsewhere in this report.
Overview
For the year ended November 30, 2014, the company had a net loss from continuing operations of $2,803,428 and a loss per share, basic and fully diluted of $0.40 as compared to a net loss from continuing ops of $3,511,282 and a loss per share, basic and fully diluted of $0.50 for the year ended November 30, 2013. For the year ended November 30, 2014 the company had a net loss from discontinued operations of $5,996,041, and loss per share, basic and fully diluted of $0.86 as compared to net loss from discontinued ops of $2,681,966, and earnings per share, basic and fully diluted, of $0.38 for the same period in fiscal 2013. The total of continuing and discontinued operations for the year

14


ended November 30, 2014 was net loss of $8,799,469 compared to a net loss of $6,193,248 for the year ended November 30, 2013.
During fiscal 2014, the Company discontinued its Gel Perfect nail polish brand and sold its Mega-T dietary supplement brand. Both brands are recorded on the financial statements as discontinued operations. On January 20, 2014, the Company announced that its Board of Directors has approved management’s plan to restructure the Company’s operations, and enter into a key business partnership with The Emerson Group. As part of this change, the Company outsourced to Emerson certain sales and administrative functions. In addition, warehousing and shipping was outsourced to Emerson and managed by OHL, one of the largest integrated global supply chain management companies in the United States. The Company’s inventory was moved to an OHL-managed facility in Indianapolis, Indiana. The Company reduced personnel from 98 employees to 37 during fiscal 2014. The restructuring plan should be complete by the end of the second quarter of fiscal 2015.
The Company entered into a contract with Suite-K Value Added Services on December 16, 2014 to provide turn-key contract manufacturing services for all products other than oral care in order to reduce and control operating costs. The contract requires a commitment to inventory purchases six months in advance and can be canceled upon 90 days notice. Under the terms of the agreement, Suite-K is responsible for purchasing the raw materials and components that are required to manufacture the products subject to the agreement. The Company will be receiving the first deliveries of product under the Suite-K turn-key contract in February 2015. The Company is discussing turn-key manufacturing with other vendors to meet its goal of being 100% turn-key for all products, which will allow the Company to operate more efficiently.
The facility that the Company occupies in East Rutherford, New Jersey is subject to a long term lease that expires in May 2022. The facility consists of a warehouse and office space. With the move of inventory to the OHL managed facility in Indianapolis, the warehouse was closed as of the end of the 2014 fiscal year. The reduction in work force as a result of the Company's restructuring plan has also resulted in the Company utilizing less than 50% of the current facilities office space. The Company is endeavoring to sub-lease the warehouse and unused portion of the office space in order to reduce overhead costs, which management believes will be completed within the third quarter of fiscal 2015.
The Company had net cash used in operations of $5,273,664 for the year ended November 30, 2014 as compared to net cash used in operations of $5,647,762 for the year ended November 30, 2013. Comprehensive loss was $8,981,847 for fiscal 2014 as compared to comprehensive loss of $6,046,117 for fiscal 2013. The Company had current assets of $11,639,499 and current liabilities of $10,738,673 at November 30, 2014. Retained earnings decreased to $5,681,403 at November 30, 2014 from $14,480,872 at November 30, 2013. The Company has a $5 million line of credit with Capital Preservation Solutions, LLC (under which $600,000 is currently outstanding) and a term loan of $1 million (all of which is currently outstanding), subject to a credit agreement that expires on December 5, 2015.
Comparison of Operating Results for Fiscal Years 2014 and 2013
For the year ended November 30, 2014, the Company had total revenues of $30,578,545 and net loss from continuing operations of $2,803,428 after a benefit from income taxes of $1,707,212. For the year ended November 30, 2013, the Company had total revenues of $28,827,163, and net loss from continuing operations of $3,511,282, after a benefit from taxes of $2,029,541. Other income increased to $458,246 for fiscal 2014 as compared to $63,794 for fiscal 2013. The increase in other income was primarily due to realized gain on sales of investments of $347,490 for fiscal 2014 compared to a realized loss on sales of investments of $4,518 in fiscal 2013. The basic and fully diluted loss per share from continuing operations for fiscal 2014 was $0.40 as compared to a basic and fully diluted loss per share from continuing operations of $0.50 for fiscal 2013.
The Company’s net sales increased to $30,120,299 for the fiscal year ended November 30, 2014 from $28,763,369 for the fiscal year ended November 30, 2013.
Sales returns and allowances was 8.7% of gross sales for fiscal 2014 and 11.7% for fiscal 2013. Coupon expense, charged against sales allowances, was $463,672 in fiscal 2014 as compared to $1,312,099 in fiscal 2013. The Company, on an ongoing basis, has returns of products that have been phased out and replaced by new items as part of its marketing plan.


15


In accordance with accounting principles generally accepted in the United States of America (“GAAP”), the Company reclassified certain advertising and promotional expenditures as a reduction of sales rather than report them as an expense, which had no effect on net income. This reclassification is in accordance with ASC Topic 605-10-S99, “Revenue Recognition” as more fully described in Note 2 (“Sales Incentives”) of the consolidated financial statements for fiscal 2014. The reclassification reflects a reduction in net sales for the fiscal years ended November 30, 2014 and 2013 by $2,964,191 and $5,081,115 respectively.
The Company’s net sales, by category for fiscal 2014 as compared to fiscal 2013 were:
 
 
 
Years Ended November 30,
 
 
2014
 
2013
Category
 
Net Sales
 
 
 
Net Sales
 
 
Skin Care
 
$
13,832,233

 
45.9
%
 
$
12,901,454

 
44.8
%
Oral Care
 
9,923,216

 
32.9
%
 
10,151,114

 
35.3
%
Nail Care
 
4,159,636

 
13.8
%
 
4,032,870

 
14.0
%
Fragrance
 
1,404,918

 
4.7
%
 
600,886

 
2.1
%
Miscellaneous
 
455,594

 
1.5
%
 
742,395

 
2.6
%
Analgesic
 
310,756

 
1.0
%
 
288,226

 
1.0
%
Hair Care
 
33,946

 
0.2
%
 
46,424

 
0.2
%
 
 
$
30,120,299

 
100.0
%
 
$
28,763,369

 
100.0
%
Net sales were affected by the following factors:
Credits for returns and cooperative advertising for the skin care category were substantially lower in fiscal 2014. Cooperative advertising was lower due to negotiating lower advertising allowances with the retailers.
Gross sales of oral care products decreased in fiscal 2014, however the decrease was offset in part by lower returns. The decrease in gross sales was due to lower distribution in fiscal 2014.
Gross sales of nail care products increased in fiscal 2014, primarily due to the launch of the Company's new Nutra Nail Health & Wellness line of products in November 2014. The Company anticipates additional roll out of sales in fiscal 2015 and full distribution in fiscal 2016.
Gross profit margins decreased to 54.7% in fiscal 2014 from 57.1% in fiscal 2013. The decrease was primarily due to the write off of obsolete inventory and the sale of excess inventory at reduced prices that increased the cost of goods sold. Excess inventory was sold in an effort to reduce the amount of inventory that the Company was carrying. The Company does not anticipate any major inventory write offs in fiscal 2015. The total cost of sales as a percentage of gross sales increased to 37.5% in fiscal 2014 as compared to 31.3% in fiscal 2013.
Selling, general and administrative expenses for fiscal 2014 were $11,794,603 as compared to $18,345,284 for fiscal 2013, a decrease of $6,550,681. The following factors contributed to the decrease:
Royalty costs decreased $82,951 in fiscal 2014 as compared to fiscal 2013 reflecting the decline in sales.
Sales commissions decreased $538,504 due to the Emerson outsourcing.
Shipping costs decreased $1,675,913 in fiscal 2014 as compared to fiscal 2013. The decrease was mainly due to the outsourcing to Emerson of warehouse operations. Emerson utilizes an OHL managed warehouse in Indianapolis, Indiana.
Personnel costs decreased $5,310,009 in fiscal 2014 as compared to fiscal 2013 due to the reduction in work force implemented as a result of the outsourcing plan, as well as decreases in overtime expense.
The decreases in selling, general and administrative expenses were offset by fees and expenses from the Emerson Group of $2,400,174.
Legal and accounting related costs increased $187,848 in fiscal 2014 as compared to fiscal 2013, due to the sale of Mega -T and financing transaction,
Public relations costs decreased $213,211 in fiscal 2014 as compared to fiscal 2013 due to the elimination of the Company's public relations consultant.
Health insurance costs decreased $701,170 in fiscal 2014 as compared to fiscal 2013 due to the reduction in work force.

16


Travel, meals and entertainment expenses decreased $322,563 in fiscal 2014 as compared to fiscal 2013 as a result of the decrease in personnel,
Consulting and related costs decreased $700,389 in fiscal 2014 as compared to fiscal 2013. The decrease was due to the resignation of David Edell and Ira Berman per their separation agreements (see Item 11, Employment Contracts for further information on the separation agreements).
The balance of the increase or decrease in expenses comprised a number of smaller expense categories.
Advertising, cooperative and promotions expenses for fiscal 2014 were $6,155,051 as compared to $2,921,199 for fiscal 2013. The increased expense of $3,233,852 was comprised of:
An increase in media, trade advertising and related expenses of approximately $2,800,000. This increase is due to increase spending on the Sudden Change, Bikini Zone, and Plus White brands, along with increase spend in commercial costs and market research.
An increase in co-operative advertising of $400,000 to support the Company's brands.
The Company’s advertising expense changes from year to year based on the timing of the Company’s promotions.
The Company recorded restructuring costs of $2,738,570 for the year ended November 30, 2014. On January 20, 2014, the Company announced that its Board of Directors has approved management’s plan to restructure the Company’s operations, and enter into a key business partnership with The Emerson Group, a premier sales and marketing company located in Wayne, Pennsylvania. As part of this change, the Company has outsourced to Emerson certain sales and administrative functions effective February 1, 2014. In addition, warehousing and shipping was outsourced to Ozburn-Hessey Logistics "OHL", one of the largest integrated global supply chain management companies in the United States. The Company’s inventory was moved to an OHL-managed facility in Indianapolis, Indiana and shipping commenced from there as of the week of February 3, 2014. A key benefit of the outsourcing move is that it shifted a substantial portion of the Company’s current fixed costs into a variable cost structure moving forward which can ultimately help keep expenses in better alignment with any future revenue generated by its brands. As part of the outsourcing plan, the Company reduced its work force from 98 to 37 employees during fiscal 2014, which resulted in a $5,177,287 annualized reduction in personnel costs. The Company has planned for additional personnel to leave in the first and second quarters of fiscal 2015. The restructuring plan should be complete by the end of the second quarter of fiscal 2015. The restructuring charge of $2,738,570 during fiscal 2014 consisted of severance payments to employees. Of this amount, $1,694,673 was paid in fiscal 2014, with the unpaid amount of $1,043,897 recorded as an accrued expense on the Company's consolidated balance sheet.
The loss before benefit from income taxes was $4,510,640 for the year ended November 30, 2014, as compared the loss before benefit from income taxes of $5,540,823 for the year ended November 30, 2013.
The effective tax provision for fiscal 2014 was a tax benefit of 37.8% of the net loss before tax as compared to a tax benefit of 36.6% of the net loss before tax for fiscal 2013. This reduction in rate is primarily due to lower state tax rates.
The Company discontinued the Gel Perfect nail polish brand and sold the Mega-T dietary supplement brand during fiscal 2014. The result of operations of both brands are recorded on the consolidated statement of operations as discontinued operations. The loss from operations of discontinued brands was $5,996,041 in fiscal 2014 as compared to a loss of $2,681,966 in fiscal 2013. The loss was higher in fiscal 2014 due to higher returns of the discontinued product, increased reserves for the Company's estimate of future returns and inventory write-offs.
Comprehensive losses, including continuing and discontinued operations, was $8,981,847 for the year ended November 30, 2014 as compared to comprehensive losses of $6,046,117 for the year ended November 30, 2013. The comprehensive loss for fiscal 2014 reflects the Company’s net loss of $2,803,428 from continuing operations, the net loss of $5,996,041 from discontinued operations, unrealized holding gains arising during fiscal 2014, net of tax of $36,888 and a reclassification adjustment for gains included in net income, net of income tax, of $219,266.



17


Superstorm Sandy
As a result of Super Storm Sandy, the Company made claims for loss against various insurance policies. In the case of one claim for $340,689, the Company did not determine the claim was realizable until May 2013 and received proceeds of $340,689 in June 2013. The Company recorded the proceeds as a reduction of selling, general and administrative expenses on the Consolidated Statements of Operations for the fiscal year ended 2013.
On October 30, 2012, Superstorm Sandy caused widespread flooding on the New Jersey coast, resulting in substantial water damage to the Company’s offices and warehouse. The Company has a flood insurance policy with a loss limit of $1,000,000. The Company received $200,000 of the insurance proceeds in November 2012 and anticipated receiving the balance of $800,000 as of November 30, 2012, and accordingly recorded an insurance receivable in the amount of $800,000 as of the same date. The Company received the balance of the proceeds of $800,000 in December 2012. The Company incurred a total net loss of $128,554 as a result of Superstorm Sandy that is recorded in the results for the year ended November 30, 2012. The following chart shows the components of the loss:

Superstorm Sandy Losses
For the year ended November 30, 2012
 
 
 
Inventory at Cost
$
437,088

Loss on Disposal of Assets Destroyed
79,893

Cleanup & Water Removal Costs
327,641

Leased Office Equipment Destroyed
145,661

Other Expenses
138,271

 
 
Total Expenses
1,128,554

Less: Insurance Proceeds
1,000,000

 
 
Net Loss
$
128,554

 
 
In addition to the net loss of $128,554, the Company’s ability to ship was interrupted for six business days which resulted in a loss of sales and profits.
Comparison of Operating Results for Fiscal Years 2013 and 2012

For the year ended November 30, 2013, the Company had revenues of $28,827,163 and net loss from continuing operations of $3,511,282 after a benefit from income taxes of $2,029,541. For the year ended November 30, 2012, the Company had revenues of $32,946,967, and net loss from continuing operations of $3,065,470, after a benefit from taxes of $1,542,312. Other income decreased to $63,794 for fiscal 2013 as compared to $606,653 for fiscal 2012. The decrease was primarily due to a decrease of $195,854 for royalty income on foreign sales and due to realized loss on sales of investments of $4,518 for fiscal 2013 compared to a realized gain on sales of investments of $121,670 in fiscal 2012. The basic and fully diluted loss per share from continuing operations for fiscal 2013 was $0.50 as compared to a basic and fully diluted loss per share of $0.43 for fiscal 2012.
The Company’s net sales decreased to $28,763,369 for the fiscal year ended November 30, 2013 from $32,340,314 for the fiscal year ended November 30, 2012.
Sales returns and allowances was 11.75 % of gross sales for fiscal 2013 and 8.09% for fiscal 2012. Coupon expense, charged against sales allowances, was $1,142,894 in fiscal 2013 as compared to $1,072,062 in fiscal 2012. The Company, on an ongoing basis, has returns of products that have been phased out and replaced by new items as part of its marketing plan.

18


In accordance with accounting principles generally accepted in the United States of America (“GAAP”), the Company reclassified certain advertising and promotional expenditures as a reduction of sales rather than report them as an expense, which had no effect on net income. This reclassification is in accordance with ASC Topic 605-10-S99, “Revenue Recognition” as more fully described in Note 2 (“Sales Incentives”) of the consolidated financial statements for fiscal 2013. The reclassification reflects a reduction in net sales for the fiscal years ended November 30, 2013 and 2012 by $2,527,744 and $5,081,115 respectively.
The Company’s net sales, by category for fiscal 2013 as compared to fiscal 2012 were: 
 
 
Years Ended November 30,
 
 
2013
 
2012
Category
 
Net Sales
 
 
 
Net Sales
 
 
Skin Care
 
$
12,901,454

 
44.8
%
 
$
16,263,317

 
50.3
%
Oral Care
 
10,151,114

 
35.3
%
 
10,626,702

 
32.8
%
Nail Care
 
4,032,870

 
14.0
%
 
3,398,420

 
10.5
%
Miscellaneous
 
742,395

 
2.6
%
 
623,710

 
1.9
%
Fragrance
 
600,886

 
2.1
%
 
1,125,308

 
3.5
%
Analgesic
 
288,226

 
1.0
%
 
252,093

 
0.8
%
Hair Care
 
46,424

 
0.2
%
 
50,764

 
0.2
%
 
 
$
28,763,369

 
100.0
%
 
$
32,340,314

 
100.0
%
Net sales were affected by the following factors:
Gross sales of skin care products decreased $2,229,451 for the year ended November 30, 2013, as compared to the same period in fiscal 2012, primarily due to slower sales. Returns of skin care products increased $920,226 for the year ended November 30, 2013 as compared to fiscal 2012, primarily attributable to Sudden Change, Solar Sense, Hand Perfection and Scar Zone products due to discontinuation of items by retailers and poor seasonal sales for Solar Sense.
Gross sales of the Company's nail care products increased $639,821 for the year ended November 30, 2013, as compared to the same period in fiscal 2012. Returns of nail care products increased $211,214 for fiscal year ended 2013 as compared to 2012.
Gross sales of oral care products decreased $914,466 for the year ended November 30, 2013 as compared to the same period in fiscal 2012, offset in part by lower returns in fiscal year 2013 as compared to fiscal year 2012.
Gross profit margins increased to 57.1 % in fiscal 2013 from 55.7% in fiscal 2012. The total cost of sales as a percentage of gross sales decreased to 31.3% in fiscal 2013 as compared to 37.2% in fiscal 2012.
Selling, general and administrative expenses for fiscal 2013 were $18,345,284 as compared to $19,422,552 for fiscal 2012, a decrease of $1,077,268. The following factors contributed to the decrease:
Shipping costs decreased $144,895 in fiscal 2013 as compared to fiscal 2012. The decrease was mainly due to decreased sales.
Personnel costs decreased $969,066 in fiscal 2013 as compared to fiscal 2012 due to the reduction in force implemented in the first, second and fourth quarters of fiscal 2013.
Legal and accounting related costs decreased $295,461 in fiscal 2013 as compared to fiscal 2012, due to the higher legal costs incurred in 2012 associated with the Alleghany Pharmacal Corporation royalty settlement.
Travel, meals and entertainment expenses decreased $72,618 in fiscal 2013 as compared to fiscal 2012.
Consulting and related costs increased $240,906 in fiscal 2013 as compared to fiscal 2012. The increase was due to contractual escalation clauses of $75,000 and use of temporary labor.

19


Public relations increased $125,696 due to the promotion of several products in 2013, as compared to just one in 2012.
The balance of the increase or decrease in expenses comprised a number of smaller expense categories.
Advertising, cooperative and promotions expenses for fiscal 2013 were $2,921,199 as compared to $3,908,329 for fiscal 2012. The decreased expense of $987,130 was comprised of:
A decrease in media, trade advertising and related expenses of $514,712.
A decrease in co-operative advertising that is recorded as a sales expense of $472,418.
The Company’s advertising expense changes from year to year based on the timing of the Company’s promotions.
The loss before benefit from income taxes from continuing operations was $5,540,823 for the year ended November 30, 2013, as compared to a loss before income taxes of $4,607,782 for the year ended November 30, 2012.
The effective tax provision for fiscal 2013 was a tax benefit of 36.6% of the net loss before tax as compared to a tax benefit of 50.7% of the net loss before tax for fiscal 2012. This reduction in rate is primarily due to lower state tax rates. As of November 30, 2013, the Company has unrealized gains on its investments of $289,021 which, if realized, would have a tax expense of $106,669.
Comprehensive loss was $6,046,117 for the year ended November 30, 2013 as compared to comprehensive income of $615,170 for the year ended November 30, 2012. The comprehensive loss for fiscal 2013 reflects the Company’s net loss from continuing operations of $3,511,282, net loss from discontinued operations of $2,681,966, unrealized holdings gains, net of tax, of $142,613 and reclassification adjustment for gains included in net income, net of tax of $4,518. The other comprehensive gain is as a result of the gain in the market value of the Company’s investments. Further information regarding the Company’s investments can be found in Note 3 of the consolidated financial statements.
Financial Position as of November 30, 2014
As of November 30, 2014, the Company had working capital of $900,826 as compared to $12,911,553 at November 30, 2013. The ratio of total current assets to current liabilities is 1.1 to 1 as of November 30, 2014, as compared to a ratio of 2.4 to 1 for the prior year. The Company’s cash position at November 30, 2014 was $241,621, versus cash and investments of $4,311,460 as at November 30, 2013. The Company had no investments at at November 30, 2014. As of November 30, 2014, there were no dividends declared.
Accounts receivable as of November 30, 2014 and 2013 were $2,248,301 and $5,473,452 respectively. Included in net accounts receivable are an allowance for doubtful accounts, a reserve for returns and allowances and a reduction based on an estimate of co-operative advertising that will be taken as credit against payments. The allowance for doubtful accounts was $25,124 and $56,513 for November 30, 2014 and 2013, respectively. The allowance for doubtful accounts is a combination of specific and general reserve amounts relating to accounts receivable. The general reserve is calculated based on historical percentages applied to aged accounts receivable and the specific reserve is established and revised based on individual customer circumstances.
The reserve for returns and allowances is based on the historical returns as a percentage of sales in the five preceding months, adjusting for returns that can be put back into inventory, and a specific reserve based on customer circumstances. This allowance increased to $3,596,399 as of November 30, 2014 from $2,070,223 as of November 30, 2013. Of this amount, allowances and reserves in the amount of $653,855, which are anticipated to be deducted from future invoices, are included in accrued liabilities. The reserve for returns and allowances was higher as of November 30, 2014 due to higher average returns and credits of 7.2% of sales for fiscal 2014 as compared to 4.3% in fiscal 2013, as well as an increase in specific reserves of $1,132,000 for Gel Perfect and $454,000 based on notification from a retailer of their intent to return product.
Gross receivables were further reduced by $592,202 as of November 30, 2014, which was reclassified from accrued liabilities, as an estimate of the co-operative advertising that will be taken as a credit against payments. In

20


addition, accrued liabilities include $2,368,808, which is an estimate of co-operative advertising expense relating to fiscal 2014 sales which are anticipated to be deducted from future invoices rather than current accounts receivable.
Inventories were $5,181,490 and $8,607,567, as of November 30, 2014 and 2013, respectively. The decline in inventory is due to lower sales, the discontinuation of the Gel Perfect nail polish brand and the sale of the Mega-T dietary supplement brand. The reserve for inventory obsolescence is based on a detailed analysis of inventory movement. The inventory obsolescence reserve decreased to $992,296 as of November 30, 2014 from $3,030,306 as of November 30, 2013. This decrease was primarily due to the reduction in inventories related to the Gel Perfect and Mega-T brands, as well as the disposal of obsolete inventory. Changes to the inventory obsolescence reserves are recorded as an increase or decrease to the cost of sales.
Prepaid expenses and sundry receivables increased to $631,204 as of November 30, 2014 from $424,626 as of November 30, 2013. The increase was in the ordinary course of business.
Prepaid and refundable income taxes decreased to $453,598 as of November 30, 2014, from $678,889 as of November 30, 2013 primarily due to the collection of tax refunds in fiscal 2014.
The amount of deferred income tax reflected as a current asset increased to $2,883,285 as of November 30, 2014 from $2,668,747 as of November 30, 2013. The $214,538 increase was primarily due to the Company's net operating losses.
The Company’s investment in property and equipment consisted mostly of leasehold improvements, office furniture and equipment, and computer hardware and software to accommodate our personnel in addition to tools and dies used in the manufacturing process. The Company acquired $69,081 of additional property and equipment during fiscal 2014.
The Company had intangible assets of $654,840 as of November 30, 2014 as compared to $762,193 as of November 30, 2013. During the fiscal year ended November 30, 2014, the Company determined to write off $90,248 of patents and trademarks, as part of its quarterly evaluation. Part of the trademarks written off included the Mega-T dietary supplement brand which was sold in August 2014 and the Gel Perfect nail polish brand which was discontinued during fiscal 2014 as part of the restructuring of its business. Other Patents and trademarks were written off that were no longer in use and did not have any plans for future use.
The Company had deferred financing fees of $1,341,458 as of November 30,2014. On September 5, 2014, the Company entered into a Loan and Security Agreement (the “Agreement”) with Capital Preservation Solutions, LLC (“Capital”) for a $5,000,000 working capital line of credit and a term loan for working capital purposes not to exceed $1,000,000. Capital Preservation Solutions, LLC is owned by Lance Funston, who also is the managing partner of Capital Preservations Holdings, LLC which owns common stock and all of the Company's Class A common stock. Contemporaneously with the signing of the Agreement, the Company issued a Warrant to Purchase Common Stock (the “Warrant”) to Capital whereby Capital may acquire upon exercise of the Warrant, 1,892,744 shares of the Company’s Common Stock. The Warrant may be exercised in whole or in part at any time during the exercise period which is five years from the date of the Warrant. The Warrant bears a purchase price of $3.17 per share, subject to adjustments. The working capital line of credit and term loan have been recorded on the consolidated balance sheet as of November 30, 2014 as from a related party. Interest and amortized financing costs in the amount of $314,213 was incurred to Capital and is recorded on the consolidated statement of operations for the year ended November 30, 2014 as interest expense from a related party. The deferred financing fees are comprised of the value of the warrant that was issued to Capital Preservation Solutions as well as related legal costs.
Current liabilities were $10,738,673 and $9,253,188, as of November 30, 2014 and 2013, respectively. Current liabilities at November 30, 2014 consisted of accounts payable, accrued liabilities and short-term capital lease obligations. As of November 30, 2014, there was $2,961,010 of open cooperative advertising commitments, of which $1,452,276 is from 2013, and $444,109 is from 2012. Of the total amount of $2,961,010, $592,202 is reflected as a reduction of gross accounts receivables, and $2,368,808 is recorded as an accrued expense. Cooperative advertising is advertising that is run by the retailers in which the Company shares in part of the cost. If it becomes apparent that this cooperative advertising was not utilized, the unclaimed cooperative advertising will be offset against the expense

21


during the fiscal year in which it is determined that it did not run. This procedure is consistent with the prior year’s methodology with regard to the accrual of unsupported cooperative advertising commitments.
Accrued liabilities included restructuring charges incurred, but not yet paid of $1,043,897. The restructuring charges are unpaid severance obligations as a result of the Company's reduction in work force during fiscal 2014. The severance charges will be fully paid by the end of the third quarter of fiscal 2015. Also included in accrued liabilities are payments due to David Edell of $450,639 and Ira Berman of $438,033 as per their respective separation agreements. On September 5, 2014, the Company entered into Separation Agreements with its two founding shareholders, David Edell and Ira Berman, (the “Founders”) whereby they are no longer required to perform any consulting services pursuant to their Amended and Restated Employment Agreements. The Company made a payment of $1,000,000 to the Founders on the separation date and is required per the Separation Agreements to make an additional payment of $200,000 to the Founders on October 1, 2015 and pay $794,620 in fifteen equal monthly installments of $52,975 commencing on October 3, 2014.
Long-Term Obligations, Credit Agreement and Issuance of Warrant
The Company’s long-term obligations are for a working capital line of credit, a term loan and a portion of its capitalized leases, which is for certain office and warehouse equipment. On September 5, 2014, the Company entered into a Loan and Security Agreement (the “Agreement”) with Capital Preservation Solutions, LLC (“Capital”) for a $5,000,000 working capital line of credit and a term loan for working capital purposes not to exceed $1,000,000. The line of credit and term loan have an interest rate of 6% and mature on December 5, 2015. The advances made under these loan agreements are subject to a borrowing base calculation that includes 80% of the eligible accounts receivable plus 50% of the value of the eligible inventory. All amounts outstanding under these agreements are secured by a first priority security interest in all of the assets of the Company. Capital is owned by Lance Funston, who is also the managing partner of Capital Preservation Holdings, LLC, which owns 219,958 shares of the Company's common stock and all of the Class A common stock. Accordingly, the line of credit and term loan are shown on the consolidated balance sheet as from a related party.
Contemporaneously with the signing of the Agreement, the Company issued a Warrant to Purchase Common Stock (the “Warrant”) to Capital whereby Capital may acquire upon exercise of the Warrant 1,892,744 shares of the Company’s Common Stock. The Warrant may be exercised in whole or in part at any time during the exercise period which is five years from the date of the Warrant. The Warrant bears a purchase price of $3.17 per share, subject to adjustments. The value of the Agreement was allocated to the relative fair values od the Loan ans Security Agreement and Warrant, resulting in an allocation of value to the Warrant of $1,456,400, which was recorded on the financial statements as additional paid-in capital as of September 5, 2014, with an asset of $1,213,667 recorded as deferred financing fees and a reduction of Term Loan- Related Party of $242,733 recorded as debt discount.
Shareholder's Equity, Cash Flow
Shareholders’ equity decreased to $9,565,954 as of November 30, 2014 from $17,062,366 as of November 30, 2013. The decrease was due to decreases in retained earnings of $8,799,469 as a result of the net loss from continuing and discontinued operations. Additional paid-in capital increased $1,485,435 due to the issuance of the warrant to Capital Preservation Solutions, LLC and issuance of stock options to employees and the directors. There were no unrealized gains on marketable securities as of November 30, 2014 as the Company sold all of its investments during fiscal 2014.
The Company's cash flow had $5,273,664 that was used in operating activities during fiscal 2014, as compared to $5,647,762 that was used by operating activities during fiscal 2013. The use in cash in fiscal 2014 was mainly due to the net loss from continuing and discontinued operations of $8,799,469, deferred income taxes of $5,342,123, an increase in accounts payable and accrued liabilities of $1,484,960 partially offset by decreases in accounts receivable of $3,249,872, inventory of $3,426,077 and a decrease in prepaid income tax of $392,366. Net cash provided by investing activities was $1,174,441 in fiscal 2014, primarily generated by the proceeds from the sale of the Company’s investments. Cash flow from financing activities increased to $1,141,824 as a result of the working capital line of credit of $600,000 and a term loan of $1,000,000 borrowed from Capital Preservation Solutions, LLC as of November 30, 2014. The Company’s cash balance decreased by $2,957,399 during fiscal 2014.

22


Liquidity and Capital Resources
Liquidity is defined as the ability to generate adequate amounts of cash to meet short-term and long-term business needs. We assess our liquidity in terms of our total cash flow and the amounts of cash and credit availability. Significant factors that could affect our liquidity include the following:
 
Cash flow generated or used by operating activities;
Restructuring liabilities due to be paid in fiscal 2015;
The ability and success of the Company being able to complete its restructuring plan;
Completion of the move to turn-key manufacturing of the Company's products;
Availability of sufficient sources of funding;
Capital expenditures.

Our primary capital needs are seasonal working capital requirements and, in the discretion of the Board of Directors, dividend payments. As of November 30, 2014, the Company had no short-term marketable securities. The Company’s long term liabilities as of November 30, 2014, consist of long-term capitalized lease obligations of $22,152, line of credit borrowings of $600,000 and a term loan of $805,813. The Company entered into an agreement with Capital for a $5,000,000 working capital line of credit and a term loan for working capital purposes not to exceed $1,000,000. The line of credit and term loan have an interest rate of 6% and mature on December 5, 2015. The advances made under the Agreement are subject to a borrowing base calculation that includes 80% of the eligible accounts receivable plus 50% of the value of the eligible inventory less certain reserves. All amounts outstanding under the Agreement are secured by a first priority security interest in all of the assets of the Company. As of November 30, 2014, we had $1,000,000 outstanding under the term loan and $600,000 outstanding under the line of credit. The term loan contains customary events of default, including failing to pay interest or principle amounts when due, if the Company becomes bankrupt or insolvent, the dissolution of the Company and certain other events more fully described in the Loan and Security Agreement filed with the 8-K by the Company on September 11, 2014. Upon the occurrence of an event of default, Capital may elect to declare the entire unpaid principal balance of the term loan and line of credit to be immediately due and payable, together with interest and all costs incurred by Capital under the loan agreement. The Company does not have any other bank debt or bank line of credit. The Company believes that it will have sufficient capital resources to meet its working capital requirements for the next twelve months. This expectation depends upon Capital providing the Company with funds under the line of credit as required and the Company’s ability to borrow additional funds under the line of credit subject to the borrowing base; our future operating performance including the absence of any unforeseen cash requirements; our ability to obtain sufficient additional financing on favorable or satisfactory terms, and the achievement of anticipated cost savings in connection with our outsourcing agreements. Our ability to obtain additional financing depends on many factors, including past operating performance, business prospects and external economic conditions.

Based on our assumptions concerning capital resources and liquidity, which include a renewal or extension of our credit facility beyond December 5, 2015, which we cannot assure, as well as achieving our internal forecast and operating plan for improved net sales, operating results and operating cash flows, anticipated credit from vendors and achieving the expected benefits from our outsourcing and restructuring plans, we anticipate that the Company will have sufficient internal and external sources of liquidity to fund operations and anticipated working capital and expected cash needs for the next twelve months. This expectation depends upon our future operating performance, the achievement of our operating plan and internal forecast, absence of unforeseen cash requirements, continuation of our credit facility availability, continued support of vendors at existing levels and the absence of any significant deterioration in economic conditions.
While we expect to see a continuation of challenging net sales and gross profit margin trends throughout the remainder of the fiscal year, our operating plan for fiscal 2015 contemplates improvements in our net sales, operating results and cash flows from operations as we progress with the implementation of our outsourcing and restructuring plans and other initiatives. Our ability to achieve our operating plan is based on a number of assumptions which involves significant judgment, risk, and estimates of future performance which we cannot assure. As a result, we cannot assure that cash flows and other sources of liquidity will at all times be sufficient for our cash requirements.

23


We will continue to monitor our performance and liquidity and if we believe operating results will be below our expectations or we determine at any time that it is appropriate or necessary to obtain additional liquidity, we will take further steps seeking to improve our financial position, such as modifying our operating plan, seeking to further reduce costs and adjust cash spend, and evaluating other alternatives and opportunities to obtain additional sources of liquidity. We cannot assure that any of these actions would be sufficient or available, or if available, available on favorable terms.
During 2014 we entered into a Loan and Security Agreement with Capital Preservation Solutions, LLC for a $5,000,000 working capital line of credit and a term loan for working capital purposes not to exceed $1,000,000. This credit agreement is due to expire by its terms on December 5, 2015, unless renewed or extended for a subsequent period, which we cannot assure. If this credit facility is not extended or renewed beyond its current term, we would seek to obtain other credit facilities to replace it. However, we cannot assure that another credit facility would be available or sufficient for our cash needs or, if available, would be on favorable terms. If our existing credit facility, which is secured by all of our material assets, is not extended or renewed as of its expiration date or replaced with another sufficient credit facility, it is likely we may not have sufficient available cash resources to satisfy such outstanding amount in full on its due date, which would have a material and adverse effect on our liquidity, financial position and business.

Critical Accounting Estimates
Our consolidated financial statements include the use of estimates, which management believes are reasonable. The process of preparing financial statements in conformity with accounting principles generally accepted in the United States (“GAAP”) requires management to make estimates and assumptions regarding certain types of assets, liabilities, revenues, and expenses. Such estimates primarily relate to unsettled transactions and events as of the date of the financial statements. Accounting estimates and assumptions are those management considers to be most critical to the financial statements because they inherently involve significant judgment and uncertainties. All of these estimates and assumptions reflect management’s best judgment about current economic and market conditions and their effects on the information available as of the date of the consolidated financial statements. Accordingly, upon settlement, actual results may differ from estimated amounts.
An accounting estimate is deemed to be critical if it is reasonably possible that a subsequent correction could have a material effect on future operating results or financial condition. The following are estimates that management has deemed to be critical:
1 - Reserve for Returns—The allowances and reserves which are anticipated to be deducted from future invoices are included in accrued liabilities. The estimated reserve is based in part on historical returns as a percentage of gross sales. The current estimated return rate is 7.20% of gross sales. Management estimates that 14.85% of returns received are placed back into inventory, and the estimate for returns is adjusted to reflect the value of the returns placed into inventory. Any changes in this accrued liability are recorded as a debit or credit to the reserve for returns and allowances account.
2 - Allowance for Doubtful Accounts – The allowance for doubtful accounts is an estimate of the loss that could be incurred if our customers do not make required payments. Trade receivables are periodically evaluated by management for collectability based on past credit history with customers and their current financial condition. Changes in the estimated collectability of trade receivables are recorded in the results of operations for the period in which the estimate is revised. Estimates are made based on specific disputes and additional reserves for bad debt based on the accounts receivable aging ranging from 0.35% for invoices currently due to 2.00% for invoices more than ninety-one days overdue. Trade receivables that are deemed uncollectible are offset against the allowance for uncollectible accounts. The Company generally does not require collateral for trade receivables.
3 - Inventory Obsolescence Reserve – Management reviews the inventory records on a monthly basis. Management deems to be obsolete finished good items that are no longer being sold, and have no possibility of sale within the ensuing twelve months. Components and raw materials are deemed to be obsolete if management has no planned usage of those items within the ensuing twelve months. In addition, management conducts periodic testing of inventory to make sure that the value reflects the lower of cost or market. If the value is below market, a provision is

24


made within the inventory obsolescence reserve. This reserve is adjusted monthly, with changes recorded as part of cost of sales in the results of operations.
4 - The deferred taxes are an estimate of the future tax consequences attributable to the temporary differences between the carrying amounts of assets and liabilities as recorded on the Company’s financial statements and the carrying amounts as reflected on the Company’s income tax return. In addition, the portion of charitable contributions that cannot be deducted in the current period and are carried forward to future periods are also reflected in the deferred tax assets. A substantial portion of the deferred tax asset is due to the loss incurred in fiscal 2014 and 2013, the benefit of which will be carried forward into future tax years.   Deferred tax assets and liabilities are valued using the tax rates expected to apply in the years in which those temporary differences are expected to be recovered or settled. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion, or all of the deferred tax asset will not be realized.  Management has estimated that it will utilize the entire deferred tax asset in future years based on its belief that the Company will be profitable.  Management expects future profitability based on the outsourcing of many functions to The Emerson Group, a substantial reduction in personnel and a reduction in other expenses.  However profits can be impacted in the future if the Company’s sales decrease.  The portion that management expects to utilize in fiscal 2015 is recorded as a short term asset, and the portion that management expects to utilize in fiscal years subsequent to fiscal 2015 are recorded as a long term asset.
5 - Co-operative advertising Reserve – The Co-operative advertising reserve is an estimate of the amount of the liability for the co-operative advertising agreements with the Company’s customers. A portion of the reserve that is estimated to be deducted from future payments is a direct reduction of accounts receivable. The portion that the Company estimates to be deducted from future invoices rather than current accounts receivable is recorded as an accrued expense. Management reviews the co-operative advertising agreements for the current fiscal year with its customers on a monthly basis and adjusts this reserve based on actual co-operative advertising events. The Company maintains an open liability for co-operative advertising contracts for which a customer has not claimed a deduction for the three years prior to the current fiscal year. Management evaluates the open liability for the prior three years on a monthly basis to determine if the liability continues to exist. Changes to the reserve are charged as a current period expense.
Inventory, Seasonality, Inflation and General Economic Factors
The Company attempts to keep its inventory for its product at levels that will enable shipment against orders within a three-week period. However, certain components must be inventoried well in advance of actual orders because of time-to-acquire circumstances. For the most part, purchases are based upon anticipated quarterly requirements, which are projected based upon sales indications received by the sales and marketing departments, and general business factors. All of the Company’s contract manufactured products and components are purchased from non-affiliated entities. Warehousing and shipping was provided at Company facilities until February 2014. Effective February 2014, the Company outsourced shipping and warehousing through Emerson to an OHL managed facility, located in Indianapolis, Indiana.
Sales of many of the Company’s products are not particularly seasonal, but sales of its sun-care, depilatory and diet-aid products usually peak during the spring and summer seasons, and perfume sales usually peak in fall and winter. The Company does not have a product that can be identified as a ‘Christmas item’ and typically does not experience any sales peak during the holiday season.
The Company plans to continue to promote its sales through an advertising program consisting of a combination of media and co-op advertising. We continue to invest money into research and development seeking to improve the competitive position of our core products in their respective categories. We are trying to decrease the amount of “on hand” inventory we stock; however to better service our customers we often find it difficult to reduce our “safety stock”.
Because our products are sold to retail stores (throughout the United States and abroad), sales are particularly affected by general economic conditions. Accordingly, any adverse change in the economic climate in the U.S. or abroad can have an adverse impact on the Company’s sales and financial condition. The Company does not believe that inflation or other general economic circumstances that would further negatively affect operations can be predicted

25


at present, but if such circumstances should occur, they could have material and negative impact on the Company’s net sales and revenues, unless the Company was able to pass along related cost increases to its customers.
Contractual Obligations
The following table sets forth the contractual obligations as of November 30, 2014. Such obligations include the Company's debt, current lease for the Company’s premises, written employment contracts and License Agreements.
 
 
 
Less than
1 Year
 
1-3 Years
 
3-5 Years
 
More than
5 years
Leases on Premises (1)
 
$
692,012

 
$
1,384,024

 
$
1,384,024

 
$
1,730,030

Royalty Expense (2)
 
290,000

 
500,000

 
500,000

 
250,000

Employment Contracts (3)
 
420,000

 
840,000

 
840,000

 
420,000

Other Operating Leases
 
167,691

 
99,313

 
20,540

 

Capital Lease Obligations
 
9,783

 
19,566

 
4,714

 

Loan and Security Agreement (5)
 
202,500

 
1,600,000

 
 
 
 
Open Purchase Orders (4)
 
4,345,409

 

 

 

Total Contractual Obligations
 
$
6,127,395

 
$
4,442,903

 
$
2,749,278

 
$
2,400,030


(1)
The lease is a net lease requiring a yearly rental of $486,012 plus Common Area Maintenance “CAM”, which includes real estate taxes, common area expense, utility expense, repair and maintenance expense and insurance expense. See Section Part I, Item 2. The rental provided above is the base rental and estimated CAM. The lease has an annual CPI adjustment, not to cumulatively exceed 30% in any consecutive five year period. The Company signed a new lease for the premises beginning June 1, 2012 and expiring May 31, 2022, with a renewal option at fair market value for an additional five years. CAM has been estimated at $206,000 per year for future years beginning June 1, 2012.
(2)
See Part I, Item 1(f). The Company is not required to pay any royalty in excess of realized sales if the Company chooses not to continue under the license. The figures set forth above reflect estimates of the anticipated minimum royalty expense required to maintain the licenses under the Alleghany Pharmacal and Joann Bradvica license agreements. The more than 5 years column only reflects one year of minimum payments for Alleghany Pharmacal; the payments can continue in perpetuity in order to maintain the license.
(3)
On March 21, 2011, the compensation committee of the board of directors, acting on behalf of the Company, entered into an Employment Agreement (each, an “Employment Agreement”) with Stephen A. Heit, and Drew Edell (each, an “Executive”). Pursuant to their respective Employment Agreements Mr. Heit was engaged to continue to serve as the Company’s Executive Vice President and Chief Financial Officer, and Mr. Edell was engaged to continue to serve as the Company’s Executive Vice President, Product Development and Production. Except as set forth below, the Employment Agreements contain substantially similar terms to each other. The initial term of employment under each of the Employment Agreements ran from March 21, 2011 through December 31, 2013, with successive one-year renewal terms thereafter unless the Company or the Executive chooses not to renew the respective Employment Agreement. Under the respective Employment Agreements, the base salaries of Mr. Heit, and Mr.  Edell were established as $250,000, and $275,000 per annum, respectively, subject to annual increases at the discretion of the Company’s Board of Directors. Mr. Heit's base salary was increased to $280,000, effective October 1, 2014. The Executives are eligible to receive an annual performance-based bonus under their respective Employment Agreement, and are entitled to participate in Company equity compensation plans. In addition, each of the Executives receives an automobile allowance, health insurance and certain other benefits. In the event of termination of the respective Employment Agreement as a result of the disability or death of the Executive, the Executive (or his estate or beneficiaries) shall be entitled to receive all base salary and other benefits earned and accrued until such termination as well as a single-sum payment equal to the Executive’s base salary and a single-sum payment equal to the value of the highest bonus earned by the Executive in the one-year period preceding the date of termination pro-rated for the number of days served in that fiscal year. If the Company terminates the Executive for Cause (as defined in the respective Employment Agreement), or the Executive terminates his employment in a manner not considered to be for Good Reason, the Executive shall be entitled to receive all base salary and other benefits earned and accrued

26


prior to the date of termination. If the Company terminates the Executive in a manner that is not for Cause or due to the Executive’s death or disability, the Executive terminates his employment for Good Reason, or the Company does not renew the Employment Agreement after December 31, 2013, the Executive shall be entitled to receive a single-sum payment equal to his unpaid base salary and other benefits earned and accrued prior to the date of termination and a single-sum payment of an amount equal to three times the average of the base salary amounts paid to Executive over the three calendar years prior to the date of termination. In addition, each Executive is entitled to certain benefits in connection with a Change of Control (as defined in their respective Employment Agreements). Under the Employment Agreements, each Executive agreed to non-competition restrictions for a period of six months following the end of the term of his Employment Agreement, during which period the Executive will be paid an amount equal to his base salary for a period of six months, and an amount equal to the pro rata share of any bonus attributable to the portion of the year completed prior to the date of termination. The Executives also agreed to confidentiality and non-solicitation restrictions under the Employment Agreements. The foregoing summary of the Employment Agreements is qualified in their entirety by the full text of the Employment Agreements, copies of which may be found in Form 8-K that was filed by Company on March 21, 2011 with the United States Securities and Exchange Commission. The Company also entered into an Employment Agreement with another Company executive, who is not a “named executive officer” within the meaning of the Securities Exchange Act of 1934, as amended and related regulations. This additional Employment Agreement contains substantially similar terms as the Employment Agreements discussed above and provides for a base salary which is currently $140,000 per annum. The Company elected to continue Mr. Stephen A. Heit's contract for 2015. The Company chose to terminate the employment of Drew Edell, effective November 30, 2014. See Item 11 below for information regarding Mr. Edell’s severance payments in connection with termination.
(4)
Open purchase orders reflect purchase orders issued as of November 30, 2014. The amount of open purchase orders has increased due to the Company moving to turn-key manufacturing with Suite-K, which requires the Company to place purchase orders for product six months in advance.
(5)
On September 5, 2014, the Company entered into a Loan and Security Agreement (the “Agreement”) with Capital Preservation Solutions, LLC (“Capital”) for a $5,000,000 working capital line of credit and a term loan for working capital purposes not to exceed $1,000,000. The line of credit and term loan have an interest rate of 6% and mature on December 5, 2015. The amount reported in the "Less than 1 year" column reflects the amount of interest expense that the Company anticipates it will incur during fiscal 2015. The amount reported in the "1-3 Years" column reflects the principle amount borrowed as of November 30, 2014 which would be due on December 5, 2015.
Recent Accounting Pronouncements
In January 2015, the Financial Accounting Standards Board ("FASB") issued ASU 2015-01, which is an update to Subtopic 225-20, "Income Statement - Extraordinary and Unusual Items". The update eliminates from United States general accepted accounting principles ("GAAP") the concept of extraordinary items. The update is effective for fiscal years, and the interim periods within those years, beginning after December 15, 2015. ASU 2015-01 is not expected to have a material impact on the Company's financial position or results of operations.
Management does not believe that any recently issued, but not yet effective, accounting standards if currently adopted would have a material effect on the accompanying financial statements.

Item 7A. QUANTITATIVE AND QUALITATIVE DISCLOSURE ABOUT MARKET RISK
The Company did not have any investments or marketable securities as of November 30, 2014.

Item 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA
The Financial Statements are listed under Item 15 in this Form 10-K. The following financial data is a summary of the quarterly results of operations (unaudited) during and for the years ended November 30, 2014 and 2013:


27


 
 
 
 
Three Months Ended
 
 
Fiscal 2014
 
Feb. 28
 
May 31
 
Aug. 31
 
Nov 30
Net Sales
 
$
8,068,006

 
$
8,761,946

 
$
7,807,019

 
$
5,483,328

Total Revenue
 
8,304,928

 
8,769,567

 
8,017,261

 
5,486,789

Cost of Sales
 
1,326,852

 
5,338,683

 
4,069,779

 
2,894,912

Gross Profit
 
6,741,154

 
3,423,263

 
3,737,240

 
2,588,416

Income (Loss) from Continued Operations
 
$
2,750,295

 
$
(1,678,514
)
 
$
(199,110
)
 
$
(3,676,099
)
(Loss) Income from Discontinued Operations
 
$
(3,838,474
)
 
$
(2,458,192
)
 
$
887,221

 
$
(586,596
)
Net (Loss) Income
 
$
(1,088,179
)
 
$
(4,136,706
)
 
$
688,111

 
$
(4,262,695
)
 Earnings (Loss) Per Share:
 
 
 
 
 
 
 
 
  Basic
 
 
 
 
 
 
 
 
Continuing Operations
 
$
0.39

 
$
(0.24
)
 
$
(0.03
)
 
$
(0.52
)
Discontinued Operations
 
$
(0.55
)
 
$
(0.35
)
 
$
0.13

 
$
(0.08
)
Total (loss) earnings per share
 
$
(0.16
)
 
$
(0.59
)
 
$
0.10

 
$
(0.60
)
Diluted
 
 
 
 
 
 
 
 
Continuing Operations
 
$
0.39

 
$
(0.24
)
 
$
(0.03
)
 
$
(0.52
)
Discontinued Operations
 
$
(0.55
)
 
$
(0.35
)
 
$
0.13

 
$
(0.08
)
Total (loss) earnings per share
 
$
(0.16
)
 
$
(0.59
)
 
$
0.10

 
$
(0.60
)


 
 
 
 
Three Months Ended
 
 
Fiscal 2013
 
Feb. 28
 
May 31
 
Aug. 31
 
Nov. 30
Net Sales
 
$
5,440,940

 
$
10,624,013

 
$
7,184,900

 
$
5,513,516

Total Revenue
 
5,443,638

 
10,679,745

 
7,176,984

 
5,526,796

Cost of Sales
 
787,924

 
4,813,126

 
3,432,693

 
3,268,613

Gross Profit
 
4,653,016

 
5,810,887

 
3,752,207

 
2,244,903

(Loss) Income from Continued Operations
 
$
(905,561
)
 
$
486,563

 
$
(929,300
)
 
$
(2,162,984
)
(Loss) Income from Discontinued Operations
 
$
(109,830
)
 
$
(643,399
)
 
$
136,408

 
$
(2,065,145
)
Net Loss
 
$
(1,015,391
)
 
$
(156,836
)
 
$
(792,892
)
 
$
(4,228,129
)
 Earnings (Loss) Per Share:
 
 
 
 
 
 
 
 
  Basic
 
 
 
 
 
 
 
 
Continuing Operations
 
$
(0.13
)
 
$
0.07

 
$
(0.13
)
 
$
(0.31
)
Discontinued Operations
 
$
(0.02
)
 
$
(0.09
)
 
$
0.02

 
$
(0.29
)
Total (loss) per share
 
$
(0.15
)
 
$
(0.02
)
 
$
(0.11
)
 
$
(0.60
)
Diluted
 
 
 
 
 
 
 
 
Continuing Operations
 
$
(0.13
)
 
$
0.07

 
$
(0.13
)
 
$
(0.31
)
Discontinued Operations
 
$
(0.02
)
 
$
(0.09
)
 
$
0.02

 
$
(0.29
)
Total (loss) per share
 
$
(0.15
)
 
$
(0.02
)
 
$
(0.11
)
 
$
(0.60
)


The Company discontinued the Gel Perfect nail polish brand and sold the Mega-T dietary supplement brand, both of which are reported as discontinued operations in the statement of operations for the each of the quarters for the years in fiscal 2014 and 2013.

28


Item 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE
During the Company’s fiscal years ended November 30, 2014, 2013, and 2012 there were (i) no disagreements between the Registrant and the Company's independent registered public accounting firm, BDO USA LLP, on any matter of accounting principles or practices, financial statement disclosures or auditing scope or procedure, which, if not resolved to the satisfaction of BDO USA LLP would have caused BDO USA LLP to make reference thereto in their reports on the financial statements for such years, and (ii) no “reportable events” as that term is defined in Item 304(a)(1)(v) of Regulation S-K.

Item 9A. CONTROLS AND PROCEDURES
Under Section 404 of the Sarbanes-Oxley Act of 2002, the Company’s fiscal 2014 annual report is required to be accompanied by a “Section 404 Formal Report” by management on the effectiveness of internal controls over financial reporting. The Company’s officers are regularly working to evaluate and confirm the effectiveness of the Company’s internal controls over financial reporting, that the Company’s data processing software systems and other procedures are effective and that the information created by the Company’s systems adequately confirm the validity of the information upon which the Company relies.
The Company regularly reviews the effectiveness of its internal controls and procedures, including financial reporting. It is working to strengthen its procedures wherever necessary.
The Company has established disclosure controls and procedures designed to provide reasonable assurance that information required to be disclosed in the reports that the Company files or submits under the Securities Exchange Act of 1934, as amended (the “Exchange Act”) is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms and is accumulated and communicated to management, including the principal executive officer (our Chief Executive Officer) and principal financial officer (our Chief Financial Officer), to allow timely decisions regarding required disclosure. Notwithstanding the foregoing, there can be no assurance that the Company’s disclosure controls and procedures will detect or uncover all failures of persons within the Company to disclose material information otherwise required to be set forth in the Company’s periodic reports. There are inherent limitations to the effectiveness of any system of disclosure controls and procedures, including the possibility of human error and the circumvention or overriding of the controls and procedures. Accordingly, even effective disclosure controls and procedures can only provide reasonable, not absolute, assurance of achieving their control objectives.
An evaluation was performed under the supervision of the Company’s management, including the Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of the Company’s disclosure controls and procedures (as defined in the Exchange Act Rules 13a-15(e) and 15d-15(e)) as of the end of the period covered by this report. Based on that evaluation, the Company’s management, including the Chief Executive Officer and Chief Financial Officer, concluded that, as of November 30, 2014, the Company’s disclosure controls and procedures were effective at the reasonable assurance level to ensure that information we are required to disclose in reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the Commission’s rules and forms, and is accumulated and communicated to our management, including the Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure.
This annual report does not include an attestation report of the Company’s independent registered public accounting firm regarding internal control over financial reporting. Management’s report was not subject to attestation by the Company’s independent registered public accounting firm pursuant to rules of the SEC that pertain to smaller reporting companies, and permit the Company to provide only management’s report in this annual report.
Management’s Report on Internal Control Over Financial Reporting
Under Section 404 of the Sarbanes-Oxley Act of 2002, our management, including our Chief Executive Officer and Chief Financial Officer, are required to assess the effectiveness of the Company’s internal control over

29


financial reporting as of November 30, 2014 and report, based on that assessment, whether the Company’s internal control over financial reporting was effective.
Management of the Company is responsible for establishing and maintaining adequate internal control over financial reporting, as defined in Rules 13a-15(f) or 15d-15(f) under the Securities Exchange Act of 1934. The Company’s internal control over financial reporting is a process designed by, or under the supervision of, our Chief Executive Officer and Chief Financial Officer to provide reasonable assurance regarding the reliability of the Company’s financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles.
The Company’s internal control over financial reporting includes those policies and procedures that: (i) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the Company; (ii) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the Company are being made only in accordance with authorizations of management and directors of the Company; and (iii) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of the Company’s assets that could have a material effect on the financial statements.
Internal control over reporting, because of its inherent limitations, may not prevent or detect misstatements. Projections of any evaluation of effectiveness for future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.
The Company’s management has assessed the effectiveness of its internal control over financial reporting as of November 30, 2014 using the criteria as set forth in Internal Control – Integrated Framework by the Committee of Sponsoring Organizations of the Treadway Commission (1992 framework). The Company’s assessment included documenting, evaluating and testing of the design and operating effectiveness of its internal control over financial reporting. Management of the Company has reviewed the results with the Audit Committee of the Board of Directors.
Based on the Company’s assessment, management has concluded that, as of November 30, 2014, the Company’s internal control over financial reporting was effective.
/s/ RICHARD KORNHAUSER                        
Richard Kornhauser, Chief Executive Officer
/s/ STEPHEN A. HEIT                    
Stephen A. Heit, Chief Financial Officer


Changes in Internal Control over Financial Reporting
No changes in the Company’s internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) occurred during the fiscal quarter ended November 30, 2014 that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.

ITEM 9B. OTHER INFORMATION
None


30


PART III

Item 10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE
The Executive Officers and Directors of the Company are as follows:
 
 
 
 
 
 
NAME
  
POSITION
  
YEAR OF FIRST
COMPANY SERVICE
 
 
 
Stanley Kreitman
  
Chairman of the Board of Directors
  
1996
 
 
 
Josephine Belli
  
Director (appointed September 5, 2014)
  
2014
 
 
 
Robert Lage
  
Director
  
2003
 
 
 
Richard Kornhauser
 
Chief Executive Officer and President. (appointed director September 5, 2014)
 
2013
 
 
 
Stephen Heit
  
Chief Financial Officer and Treasurer. (appointed director September 5, 2014)
  
2005
 
 
 
Stanley Kreitman, age 82, is Chairman of the Board of Directors of the Company. He has been Vice Chairman of Manhattan Associates an equity investment firm since 1994. He is a director of Medallion Financial Corp. (NASDAQ). Within the last five years, Mr Kreitman has held directorship positions at the following public companies: CapLease Inc. (formerly Capital Lease Financial Corp.) (NYSE), KSW,Inc. (listed on NASDAQ until its acquisition in 2012), Arbinet Corporation (listed on NASDAQ until its acquisition in 2011), and Sports Properties Acquisition Corp. and Renaissance Acquisition Corp. each of which was a special purpose company. He also serves as a director of the New York City Board of Corrections, Nassau County Crime Stoppers , and serves on the board of the Police Athletic League. From 1975 to 1993 he was President of the United States Banknote Corp. (NYSE), a securities printer.
Director Qualifications
Leadership experience as President of United States Banknote Corporation and Vice Chairman of Manhattan Associates
Extensive experience serving on boards of directors of various corporations and organizations
Deemed by the Board of Directors to be an “audit committee financial expert” as defined by the SEC rules and “financially sophisticated” as defined by the NYSE-MKT rules.

Josephine Belli, age 57, is an attorney with the law firm of Goldberg Segalla, LLP. Ms. Belli previously served in various positions including Senior Counsel with Combe Incorporated, a manufacturer, marketer and distributor of drugs, devices and personal care products. Ms. Belli is a graduate of St. John’s University School of Law and is a member of the New York State bar, as well as the bars for the Court of International Trade and the Eastern District of New York Court of Appeals for the Federal Circuit.
Director Qualifications
Attorney familiar with laws pertaining to public companies and regulations for international trade
Experience as former senior counsel with a large comsumer products company marketing similar products
Deemed by the Board of Directors to be an “audit committee financial expert” as defined by the SEC rules and “financially sophisticated” as defined by the NYSE-MKT rules.


31


Robert Lage, age 78, is a director of the Company, and a retired CPA. He was a partner at Pricewaterhouse Coopers Management Consulting Service prior to his retirement in 1997. He has been engaged in the practice of public accounting and management consulting since 1959. He received a BBA from Bernard Baruch College of the City University of New York in 1958.
Director Qualifications
Certified Public Accountant since 1959
Extensive experience as a partner at Price Waterhouse Coopers Management Consulting Service
Deemed by the Board of Directors to be an “audit committee financial expert” as defined by the SEC rules and “financially sophisticated” as defined by NYSE-MKT rules
Richard Kornhauser, age 60, joined CCA in October 2013 as Chief Executive Officer and President. Before joining CCA, he was Chief Executive Officer of RK Brands, LLC from July 2010 through September 2013. Previously, Mr. Kornhauser held senior management positions with FGX International as Chief Marketing Officer from 2008 to 2010, with Chattem, Inc. as Vice President of Marketing from 2000 through 2007, and with Combe Inc. as Group Vice President of Marketing from 1990 to 2000. He attended Columbia University. Mr. Kornhauser has over thirty years of experience in the health and beauty aids industry at companies with very similar problem-solution brands to CCA Industries: Chattem, Incorporated, Combe Incorporated, and FGX International. Mr. Kornhauser was instrumental in spearheading the marketing and advertising efforts which helped drive significant, and profitable growth for such brands as: Gold Bond® skin care, Icy Hot® topical analgesics, Selsun-Blue® dandruff shampoo, Sea Bond® denture care, Odor-Eaters® foot care, and the iconic Foster Grant® eyewear brand.

Stephen A. Heit, age 60, joined CCA in May 2005 as Executive Vice President – Operations, and was appointed Chief Financial Officer in March 2006. Prior to that he was Vice President – Business Strategies for Del Laboratories, Inc., a consumer products company that was listed on the American Stock Exchange, from 2003 to 2005. Mr. Heit served as President of AM Cosmetics, Inc. from 2001 to 2003 and as Chief Financial Officer from 1998 to 2003. From 1986 to 1997 he was the Chief Financial Officer of Pavion Limited, and also served on the Board of Directors. He served as a Director of Loeb House, Inc., a non-profit organization serving mentally handicapped adults from 1987 to 1995, and Director of Nyack Hospital Foundation from 1993 to 1995. He received a Bachelor of Science from Dominican College in 1976, with additional graduate work in Professional Accounting at Fordham University, and received an MBA in accounting from the University of Connecticut Graduate Business School.
Committees of the Board of Directors
The Board of Directors has established three committees. The audit committee is comprised solely of independent directors, Robert Lage, who serves as its’ Chairman, Stanley Kreitman, and Josephine Belli. Directors Belli, Lage and Kreitman each qualify as an “audit committee financial expert” as defined by the SEC, are “independent” as that term is used in Section 10(m)(3) of the Exchange Act and NYSE-MKT rules and are “financially sophisticated” as defined by NYSE-MKT rules. The compensation committee is comprised of Stanley Kreitman, Robert Lage and Josephine Belli. Each member of the compensation committee is “independent” as defined by NYSE-MKT rules. The nominating committee is comprised of Stanley Kreitman and Robert Lage.
Section 16(a) Beneficial Ownership Reporting Compliance
Section 16(a) of the Securities Exchange Act of 1934 requires our executive officers and directors and beneficial owners of more than ten percent of the Company’s Common Stock to file reports regarding ownership of the Company’s Common Stock with the SEC, and to furnish the Company with copies of all such filings. Based solely on a review of these filings, the Company believes that all filings were timely made in fiscal 2014, except for a late Form 4 filed by Mr. Kornhauser reporting two late purchases that occurred in April 2015, a Form 4 filed by Mr. Kornhauser on May 19, 2015 reporting nine purchases that occurred on May 5 through May 8, 2015, a late Form 3 filed by Lance Funston, and four late Forms 4 reporting the option grants to Mr. Kornhauser in February 2014 and to each of Messrs. Kreitman and Lage and Ms. Belli on October 2, 2014.



32



Code of Ethics
The Company had adopted Standards of Business Conduct (our code of ethics), which apply to all directors and employees of the Company, including the Chief Executive Officer and Chief Financial Officer. A copy of the Standard of Business Conduct may be found in the investor section of the Company’s web site, www.ccaindustries.com, under Corporate Governance. The Company intends to disclose any substantive amendments to the Standards of Business Conduct as well as any waivers from provisions such document made with respect to our Chief Executive Officer, Chief Financial Officer, any principal accounting officer, and any other executive officer or any director at the same web site location. A print copy of our Standards of Business Conduct will be provided to any person upon request and without charge by writing to the following address: CCA Industries Inc., 200 Murray Hill Parkway, East Rutherford, NJ 07073, Attention: Secretary.

Item 11. EXECUTIVE COMPENSATION
i. Summary Compensation Table
The following table summarizes compensation earned in the 2014, 2013 and 2012 fiscal years by the following named officers:
 
Name and Principal Position
 
Year
 
Salary
($)
 
Bonus
($) (1)
 
All Other
Compensation
($) (2)
 
Total
($)
Richard Kornhauser, Chief Executive Officer and
 
2014
 
456,000

 
150,000

 
29,608

 
635,608

 President (3)
 
2013
 
58,846

 

 

 
58,846

Stephen A. Heit, Chief Financial Officer
 
2014
 
264,948

 
24,000

 
35,582

 
324,530

and Executive Vice President
 
2013
 
250,000

 

 
30,344

 
280,344

 
 
2012
 
250,000

 

 
28,513

 
278,513

Drew Edell (4)
 
2014
 
279,183

 

 
1,028,871

 
1,308,054

Executive Vice President
 
2013
 
275,000

 

 
24,195

 
299,195

 
 
2012
 
275,000

 

 
22,690

 
297,690

(1)
Bonus amounts represent amounts earned in each respective fiscal year, not necessarily paid in each year.
(2)
Includes the personal use value of Company leased automobiles, the value of Company-provided life insurance, and health insurance that is made available to all employees. Please see Item. 11, Section v.—Employment Contracts/Compensation Program for further information regarding the compensation of Richard Kornhauser, Stephen A. Heit and Drew Edell.
(3)
Richard Kornhauser was named Chief Executive Officer and President in October 2013.
(4)
Drew Edell's employment with the Company ended effective November 30, 2014. The amount reported here includes $1,001,875 of payments to be made to Mr. Edell in connection with his termination of employment.

ii. Outstanding Management Equity Awards at 2014 Fiscal Year End
On February 1, 2014, the Company granted incentive stock options for 100,000 shares to Richard Kornhauser, its President and Chief Executive Officer at $3.40 per share. The closing price of the Company's stock on the date of the grant was $3.04 per share. The options vest in equal 20% increments commencing on October 17, 2014, and for each of the four subsequent anniversaries of such date. The options expire on January 31, 2019. The Company has estimated the fair value of the options granted to be $114,000 as of the grant date, which amount shall be amortized as an expense over a five year period. There were no other stock options for named executive officers granted or options exercised during fiscal 2014.


33


iii. Compensation of Directors
The following table reports the fees earned or paid in cash to each director, with respect to their service as directors, during fiscal 2014. Other than these fees, no other compensation was paid to our non-employee directors in 2014.
 
 
 
Director
Year Ended
Nov. 30, 2014
Josephine Belli (appointed director September 5, 2014)
5,042

Sardar Biglari (resigned effective July 1, 2014)
3,125

Philip Cooley (resigned effective July 1, 2014)
3,125

David Edell (resigned effective September 5, 2014)
38,125

Stanley Kreitman
34,167

Robert Lage
44,083

Jonathan Rothschild (resigned effective December 31, 2014)
22,917

 
Effective October 2014, the Board of Directors approved the following fees: Chairman of the Board - $4,000 per month with no additional compensation for board meetings; Chairman of the Audit Committee - $13,000 retainer per annum in addition to other director fees; Non-executive directors - $12,000 retainer per annum; Board meetings (other than the Chairman of the Board) - $2,000 for in-person meetings and no payment for attendance by telephone. The Board of Directors met five times in person during fiscal 2014, and four additional times by conference call, for an aggregate compensation of $150,584, including Mr. Kreitman’s additional compensation of $15,000 as Chairman of the Board, and Mr. Lage’s additional compensation of $30,000 as chairman of the audit committee. Non-qualified stock options were granted to three directors on October 2, 2014. Stanley Kreitman and Robert Lage were granted options for 10,000 shares each at $3.42 per share, and Josephine Belli was granted options for 7,000 shares at $3.42 per share. The closing price of the Company's stock on the date of the grant was $3.42 per share. The options vest on October 2, 2015, subject to the grantee's continuous service as Director through that date. The options expire on October 1, 2024.
iv. Executive Compensation Principles—Compensation Committee
The Company’s Executive Compensation Program is based on guiding principles designed to align executive compensation with Company values and objectives, business strategy, management initiatives, and financial performance. In applying these principles the Compensation Committee of the Board of Directors, comprised of Stanley Kreitman, Robert Lage and Josephine Belli has established a program to:
Reward executives for long-term strategic management and the enhancement of shareholder value.
Integrate compensation programs with both the Company’s annual and long-term strategic planning.
Support a performance-oriented environment that rewards performance not only with respect to Company goals but also Company performance as compared to industry performance levels.
The Compensation Committee has a charter, which may be found in the investor section of the Company’s web site, www.ccaindustries.com under Corporate Governance. Compensation, including annual bonus amounts, for the executive officers named in the Summary Compensation Table (other than the Chief Executive Officer), are recommended by the Chief Executive Officer, and approved by the Compensation Committee and the Board of Directors.
v. Employment Contracts/Compensation Program
The Compensation Committee (the “Committee”) determines the level of salary and bonuses, if any, for key executive officers of the Company. The Committee determines the salary or salary range based upon competitive norms. Actual salary changes are based upon performance, and bonuses, if any, are awarded by the Committee and approved by the independent directors of the board in consideration of the employee’s performance during the fiscal

34


year and, except for the Company’s Chief Executive Officer, upon the recommendation of the Company’s Chief Executive Officer.
On March 21, 2011, the Committee, acting on behalf of the Company, entered into an Employment Agreement (each, an “Employment Agreement”) with Stephen A. Heit, and Drew Edell (each, an “Executive”). Pursuant to their respective Employment Agreements, Mr. Heit has been engaged to continue to serve as the Company’s Executive Vice President and Chief Financial Officer, and Mr. Drew Edell was engaged to continue to serve as the Company’s Executive Vice President, Product Development and Production.
Mr. Drew Edell is the son of David Edell, who was a member of the Board of Directors of the Company and served as a consultant to the Company. Except as set forth below, the Employment Agreements contain substantially similar terms to each other. The initial term of employment under each of the Employment Agreements ran from March 21, 2011 through December 31, 2013, with successive one-year renewal terms thereafter unless the Company or the Executive chooses not to renew the respective Employment Agreement. The Company chose not to renew the employment contract of Drew Edell, effective November 30, 2014. Under the terms of Drew Edell's Employment Agreement, he is entitled to certain payments and benefits, including a payment of his base salary for six months after termination and a lump-sum payment of $825,000 , which is due to be paid in June 2015. Mr. Heit's contract was automatically renewed for 2015.
Under the respective Employment Agreements, the base salaries of Mr. Stephen A. Heit, and Mr. Drew Edell (the “Executives”) are $250,000 and $275,000 per annum, respectively, and may be increased each year at the discretion of the Company’s Board of Directors. Mr. Heit's base salary was increased to $280,000, effective October 1, 2014. The Executives are eligible to receive an annual performance-based bonus under their respective Employment Agreement, and are entitled to participate in Company equity compensation plans. In addition, each of the Executives will receive an automobile allowance, health insurance and certain other benefits. In the event of termination of the respective Employment Agreement as a result of the disability or death of the Executive, the Executive (or his estate or beneficiaries) shall be entitled to receive all base salary and other benefits earned and accrued until such termination as well as a single-sum payment equal to the Executive’s base salary and a single-sum payment equal to the value of the highest bonus earned by the Executive in the one-year period preceding the date of termination pro-rated for the number of days served in that fiscal year. If the Company terminates the Executive for Cause (as defined in the respective Employment Agreement), or the Executive terminates his employment in a manner not considered to be for Good Reason (as defined in the respective Employment Agreement), the Executive shall be entitled to receive all base salary and other benefits earned and accrued prior to the date of termination. If the Company terminates the Executive in a manner that is not for Cause or due to the Executive’s death or disability, the Executive terminates his employment for Good Reason, or the Company does not renew the Employment Agreement after December 31, 2013, the Executive shall be entitled to receive a single-sum payment equal to his unpaid base salary and other benefits earned and accrued prior to the date of termination and a single-sum payment of an amount equal to three times the average of the base salary amounts paid to Executive over the three calendar years prior to the date of termination. In addition, each Executive is entitled to certain benefits in connection with a Change of Control (as defined in their respective Employment Agreements).
Under the Employment Agreements, each Executive has agreed to non-competition restrictions for a period of six months following the end of the term of his Employment Agreement, during which period the Executive will be paid an amount equal to his base salary for a period of six months, and an amount equal to the pro rata share of any bonus attributable to the portion of the year completed prior to the date of termination. The Executives have also agreed to confidentiality and non-solicitation restrictions under the Employment Agreements.
The foregoing summary of the Employment Agreements is qualified in its entirety by the full text of the Employment Agreements, copies of which may be found in Form 8-K that was filed by Company on March 21, 2011 with the United States Securities and Exchange Commission.
The Company also entered into an Employment Agreement with another Company executive, who is not a “named executive officer” within the meaning of the Securities Exchange Act of 1934, as amended and related regulations. The additional Employment Agreement referred to in the preceding sentence contains substantially similar

35


terms as the Employment Agreements discussed above, except that the employee’s base salary is $135,000 per annum, which was increased to $140,000 in the fourth quarter of fiscal 2014.
In October 2013, Richard Kornhauser was appointed as Chief Executive Officer and President with a salary of $450,000 per annum. There is no employment contract with Mr. Kornhauser.
The Company was also party to an employment agreement providing for a consulting arrangement and change of control agreement with each of David Edell and Ira Berman, the two founding shareholders of the Company (the “Founders”). On September 5, 2014, the Company entered into Separation Agreements with the Founders terminating their employment agreements and their change in control agreements as of that date. In consideration for the termination of these agreements, the Company made a payment of $1,000,000 in the aggregate to the Founders in September 2014. The Company is further required under the Separation Agreements to make an additional payment in the aggregate of $200,000 to the Founders on October 1, 2015 and to pay $794,620 in the aggregate in fifteen equal monthly installments of $52,975 commencing on October 3, 2014. The $794,620 represents the aggregate amount that had been due to Messrs. Edell and Berman through September 5, 2014 under their employment agreements, of which $794,620 had been previously reserved for in the Company’s financial statements. See Item 7 - Contractual Obligations and Item 13 for additional information regarding the consulting arrangement.
vi. Retirement Benefits
The Company has adopted a 401(K) Profit Sharing Plan that covers all employees with over one year of service and attained age 21, including the executive officers named in the Summary Compensation Table. Employees may make salary reduction contributions up to twenty-five percent of compensation not to exceed the federal government limits. The Plan allows for the Company to make discretionary contributions. For all Fiscal periods reflected in the Summary Compensation Table, the Company did not make any contributions.

vii. Equity Plans
Long-term incentives may be provided through the issuance of stock options or other equity awards, as determined in the discretion of the Board of Directors.
On June 15, 2005, the shareholders approved an amended and Restated Stock Option Plan amending the 2003 Stock Option Plan (the “Plan”). The Plan authorizes the issuance of up to one million shares of common stock (subject to customary adjustments set forth in the plan) pursuant to equity awards, which may take the form of incentive stock options, nonqualified stock options restricted shares, stock appreciation rights and/or performance shares.
On February 1, 2014, the Company granted incentive stock options for 100,000 shares to Richard Kornhauser, its President and Chief Executive Officer at $3.40 per share. The closing price of the Company's stock on the date of the grant was $3.04 per share. The options vest in equal 20% increments commencing on October 17, 2014, and for each of the four subsequent anniversaries of such date. The options expire on January 31, 2019.
Non-qualified stock options were granted to three directors on October 2, 2014. Stanley Kreitman and Robert Lage were granted options for 10,000 shares each at $3.42 per share, and Josephine Belli was granted options for 7,000 shares at $3.42 per share. The closing price of the Company's stock on the date of the grant was $3.42 per share. The options vest on October 2, 2015, subject to the grantee's continuous service as Director through that date. The options expire on October 1, 2024.
On October 16, 2014, the Company granted incentive stock options for 10,000 shares to Gail Perlow, a Company employee, at $3.36 per share. The closing price of the Company's stock on the date of grant was $3.36 per share. The options vest in equal 20% increments commencing on October 16, 2015, and for each of the four subsequent anniversaries of such date. The options expire on October 15, 2024.
Awards may be granted under the Plans to employees (including officers and directors who are also employees) of the Company provided, however, that Incentive Stock Options may not be granted to any non-employee director or consultant.

36


The Plan is administered and interpreted by the Board of Directors. (Where issuance to a Board member is under consideration, that member must abstain.) The Board has the power, subject to plan provisions, to determine the persons to whom and the dates on which awards will be granted, the amount and vesting or exercise provisions of awards, and other terms. The Board has the power to delegate administration to a committee of not less than two (2) Board members, each of whom must be a “non-employee director” within the meaning of Rule 16b-3 under the Securities Exchange Act. Members of the Board receive no compensation for their services in connection with the administration of option plans.
The Plan permits the exercise of options for cash, or such other method as the Board may permit from time to time.
The maximum term of each option is ten (10) years. No option granted is transferable by the optionee other than upon death.
The exercise price of all options must be at least equal to one hundred percent (100%) of the fair market value of the underlying stock on the date of grant. The aggregate fair market value of stock of the Company (determined at the date of the option grant) for which any employee may be granted Incentive Stock Options in any calendar year may not exceed $100,000, plus certain carryover allowances. The exercise price of an Incentive Stock Option granted to any participant who owns stock possessing more than ten percent (10%) of the voting rights of the Company’s outstanding capital stock must be at least one hundred-ten percent (110%) of the fair market value on the date of grant. As of November 30, 2014, there were 137,000 outstanding stock options under the Plan.

37


viii. Performance Graph
Set forth below is a line graph comparing cumulative total shareholder return on the Company’s Common Stock, with the cumulative total return of companies in the Dow Jones US Index and the cumulative total return of Dow Jones’s Personal Products Index.
Copyright© 2014 Dow Jones & Company. All rights reserved. 
 
 
11/09
 
11/10
 
11/11
 
11/12
 
11/13
 
11/14
CCA Industries, Inc.
 
100.00

 
133.20

 
133.42

 
123.45

 
91.91

 
99.79

Dow Jones US Total Return
 
100.00

 
112.17

 
120.36

 
139.60

 
182.87

 
212.38

Dow Jones US Personal Products
 
100.00

 
99.45

 
116.83

 
135.05

 
177.55

 
180.67

The Performance Graph in this Item 11 is not deemed to be “soliciting material” or to be “filed” with the SEC or subject to Regulation 14A or 14C under the Securities Exchange Act of 1934 or to the liabilities of Section 18 of the Securities Exchange Act of 1934 and will not be deemed to be incorporated by reference into any filing under the Securities Act of 1933 or the Securities Exchange Act of 1934, except to the extent we specifically incorporate it by reference into such a filing.


38


Item 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED SHAREHOLDER MATTERS
The following table sets forth information as of November 30, 2014 with respect to compensation plans under which shares of the Company’s Common Stock may be issued:
EQUITY COMPENSATION PLAN INFORMATION
 
Plan Category
 
Number of shares
to be issued upon
exercise of out-
standing options
warrants and
rights
 
Weighted-
average
exercise price
of outstanding
options
 
Number of shares
remaining and
available for
future issuance
under equity
compensation
plans (excluding
shares in the first
column)
Equity compensation plans approved by security holders
 
127,000

 
$
3.40

 
873,000

Equity compensation plans not approved by security holders
 

 

 

Total
 
127,000

 
$
3.40

 
873,000


39


The following table sets forth certain information regarding the ownership of the Company’s Common Stock, Class A Common Stock and ownership of all shares outstanding as of February 12, 2015 by (i) each of the directors (ii) each of the named executive officers listed in the summary compensation table and (iii) each person that the Company is aware to be the beneficial owner of more than five percent of the outstanding shares of Common Stock and/or Class A Common Stock and (iv) all current officers and directors as a group. Unless otherwise indicated, each of the shareholders has sole voting and investment power with respect to the shares owned (subject to community property laws, where applicable), and is the beneficial owner of them.

Beneficial Ownership of Equity Securities
 
 
 
 
 
 
 
Ownership
 
Ownership
 
Ownership
 
Ownership
 
 
Number of Shares Owned
 
Percentage of
 
Percentage of
 
Percentage of
 
Percent
Name
 
Common  Stock
 
Class A
Common  Stock
 
Common Stock
Outstanding (2)
 
Class A Stock
Outstanding (1)
 
All Shares
Outstanding
Option/Warrant Shares
Assuming Option/Warrant Exercise
Josephine Belli



—%

—%

—%
7,000
*
Stanley Kreitman

14,200


*

—%

*
10,000
*
Robert Lage



—%

—%

—%
10,000
*
Richard Kornhauser

5,486


*

—%

*
100,000
1.4%
Stephen A. Heit

2,680


*

—%

*
*
Drew Edell (6)
 
98,108
 
 
*
 
1.6%
 
*
1.4%
Lance Funston (1)

219,958

967,702

3.6%

100.0%

17.0%
17.0%
Sardar Biglari (2)

776,259


12.9%

—%

11.1%
11.1%
Renaissance Technologies LLC (3)

317,300


5.3%

—%

4.3%
4.3%
Capital Preservation Solutions, LLC (4)



—%

—%

—%
1,892,744
21.3%
Officers & Directors
As a Group (5 persons)

22,366


0.4%

—%

0.3%
127,000
2.1%
*
Represents less than one percent (1%) of the outstanding shares of the class.
(1)
Includes shares owned by Capital Preservation Holdings, LLC which is controlled by Lance Funston. Richard Kornhauser and Stephen A. Heit have a minority interest in Capital Preservation Holdings, LLC, but do not have any voting rights.
(2)
Based on information contained in Schedule 13-D/A filed on August 8, 2011with the SEC by Biglari Holdings Inc., the amount reported included 388,130 shares held by Biglari Holdings Inc. until July 1, 2013. Based upon information in SEC Form 4, on July 1, 2013, the 388,130 shares held by Biglari Holdings Inc. were acquired by the Lion Fund, L.P.(“The Lion Fund”), which when combined with the previous 388,129 shares held by the Lion Fund results in the total of 776,259 shares currently held by the The Lion Fund. Biglari Capital Corp. (“BCC”) is the general partner of the Lion Fund. Sardar Biglari is the founder, Chairman and Chief Executive Officer of BCC and has investment discretion over the securities owned by the Lion Fund. By virtue of these relationships, BCC and Sardar Biglari may be deemed to beneficially own the 776,259 shares owned directly by The Lion Fund. BCC and Sardar Biglari each expressly and respectively disclaims beneficial ownership of such shares except to the extent of their respective pecuniary interest therein. The principal business address of each of Biglari Holdings, Inc., Sardar Biglari, BCC and The Lion Fund is 17802 IH 10 West, Suite 400, San Antonio, Texas 78257.
(3)
Based on information contained in Schedule 13G under rule 13d-1, filed on February 12, 2015 with the SEC by Renaissance Technologies LLC ("RTC") and Renaissance Technologies Holdings Corporation ("RTHC"). The amount reported included 304,300 shares beneficially owned by RTHC, because of RTHC's majority ownership in RTC. The principal address for both entities is 800 Third Avenue, New York, New York 10022.
(4)
Capital Preservation Solutions, LLC is owned by Lance Funston. On September 5, 2014, the Company entered into a Loan and Security Agreement (the “Agreement”) with Capital Preservation Solutions, LLC (“Capital”) for a $5,000,000 working capital line of credit and a term loan for working capital purposes not to exceed $1,000,000. Contemporaneously with the signing of the Agreement, the Company issued a Warrant to Purchase Common Stock (the “Warrant”) to Capital whereby Capital may acquire upon exercise of the Warrant 1,892,744 shares of the Company’s Common Stock. The Warrant may be exercised in whole or in part at any time during the exercise period which is five years from the date of the Warrant. The Warrant bears a purchase price of $3.17 per share, subject to adjustments.

40


(5)
The number of “Option /Warrant Shares” represents the number of shares that could be purchased by, and upon exercise of unexercised options/warrants; and the percentage ownership figure denominated “Assuming Option/Warrant Exercise” assumes, per person, that unexercised options/warrants have been exercised and, thus, that subject shares have been purchased and are actually owned. In turn, the “assumed” percentage ownership figure is measured, for each owner, as if each had exercised such options, and purchased subject ‘option shares,’ and thus increased total shares actually outstanding, but that no other option owner had ‘exercised and purchased.’
(6)
Mr. Drew Edellin no longer an Employee of CCA Industries, Inc. as of November 30, 2014.

Item 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE
During fiscal years 2014 and 2013, as per their respective Employment Agreements, the Company made payments of $366,914 and $381,460 each to David Edell and Ira Berman for consulting services provided during those years and certain other benefits as per their Employment Agreements. David Edell served as a director during fiscal 2014 until September 5, 2014. Ira Berman is a former director. On September 5, 2014, the Company entered into Separation Agreements with David Edell and Ira Berman, (the “Founders”) whereby they are no longer required to perform any consulting services pursuant to their Amended and Restated Employment Agreements. The Company made a payment of $1,000,000 in the aggregate to the Founders on the separation date and is required per the Separation Agreements to make an additional payment of $200,000 in the aggregate to the Founders on October 1, 2015 and pay $794,620 in the aggregate in fifteen equal monthly installments of $52,975 commencing on October 3, 2014. See Item 7 - Contractual Obligations and for additional information regarding the consulting arrangement.
On September 5, 2014, the Company entered into a Loan and Security Agreement (the “Agreement”) with Capital Preservation Solutions, LLC (“Capital”) for a $5,000,000 working capital line of credit and a term loan for working capital purposes not to exceed $1,000,000. Capital Preservation Solutions, LLC is owned by Lance Funston, who also is the managing partner of Capital Preservations Holdings, LLC which owns common stock and all of the Company's Class A common stock. Contemporaneously with the signing of the Agreement, the Company issued a Warrant to Purchase Common Stock (the “Warrant”) to Capital whereby Capital may acquire upon exercise of the Warrant 1,892,744 shares of the Company’s Common Stock. The Warrant may be exercised in whole or in part at any time during the exercise period which is five years from the date of the Warrant. The Warrant bears a purchase price of $3.17 per share, subject to adjustments. The working capital line of credit and term loan have been recorded on the consolidated balance sheet as of November 30, 2014 as from a related party. Interest and amortized financing costs in the amount of $314,213 was incurred to Capital and is recorded on the consolidated statement of operations for the year ended November 30, 2014 as interest expense from a related party.
The independent directors of the Company are: Josephine Belli, Robert Lage and Stanley Kreitman. There were no transactions, relationships or arrangements not disclosed in this item that would need to be considered by the Company’s board of directors in determining the director’s independence.

Item 14. PRINCIPAL ACCOUNTANT FEES AND SERVICES
BDO USA, LLP (“BDO”) served as the Company’s independent registered public accounting firm for 2014 and 2013. The services performed by BDO in this capacity included conducting an audit in accordance with generally accepted audit standards of, and expressing an opinion on, the Company’s consolidated financial statements.
Audit Fees
BDO’s fees for professional services rendered in connection with the audit and review of Forms 10-K and all other SEC regulatory filings were $175,000 per annum for each of the 2014 and 2013 fiscal years. The Company has paid and is current on all billed fees.

Audit Related Fees
There were no audit related fees in fiscal 2014 or fiscal 2013.


41


Tax Fees
BDO’s fees for professional services rendered in connection with Federal and State tax return preparation and other tax matters for each of the 2014 and 2013 fiscal years was $45,000 per annum. In addition, the Company paid BDO $10,000 in fiscal year 2013 for a study of tax nexus.
All Other Fees
There were no other fees in fiscal 2014 or fiscal 2013.
Engagements Subject to Approval
Under its charter, the Audit Committee must pre-approve all subsequent engagements of our independent registered public accounting firm unless an exception to such pre-approval exists under the Securities Exchange Act of 1934 or the rules of the Securities and Exchange Commission. Each year, before a independent registered public accounting firm is retained to audit our financial statements, such service and the associated fee, is approved by the committee. At the beginning of the fiscal year, the Audit Committee will evaluate other known potential engagements of the independent registered public accounting firm, including the scope of the work proposed to be performed and the proposed fees, and approve or reject each service, taking into account whether the services are permissible under applicable law and the possible impact of each non-audit service on the independent registered public accounting firm’s independence from management. At each subsequent committee meeting, the committee will receive updates on the services actually provided by the independent registered public accounting firm, and management may present additional services for approval. The committee has delegated to the Chairman of the committee the authority to evaluate and approve engagements on behalf of the committee in the event that a need arises for pre-approval between committee meetings. If the Chairman so approves any such engagements, he will report that approval to the full committee at the next committee meeting.


42


PART IV

Item 15. EXHIBITS, FINANCIAL STATEMENTS, SCHEDULES
 
(a) (1) 
Financial Statements:
Table of Contents, Report of Independent Registered Public Accounting Firm, Consolidated Balance Sheets as of November 30, 2014 and 2013, Consolidated Statements of Operations for the years ended November 30, 2014, 2013 and 2012, Consolidated Statements of Comprehensive (Loss) Income for the years ended November 30, 2014, 2013 and 2012, Consolidated Statements of Shareholders’ Equity for the years ended November 30, 2014, 2013 and 2012, Consolidated Statements of Cash Flows for the years ended November 30, 2014, 2013 and 2012, Notes to Consolidated Financial Statements.
Financial Statement Supplementary Information:
 
(a) (2) 
Schedule II: Valuation Accounts; Years Ended November 30, 2014, 2013 and 2012.
 
(a) (3) 
Exhibits: The following exhibits are filed herewith or incorporated by reference
(2.1) Asset Purchase Agreement, dated August 26, 2014, between CCA Industries, Inc. and Mega-T, LLC is incorporated by reference to Exhibit 2.1 to the Company’s Form 8-K filed September 2, 2014.
(3.1) The Company’s Articles of Incorporation and Amendments thereof, are incorporated by reference to its filing on Form 10-K/A filed April 5, 1995. (SEC file number reference 000-12723) (Exhibit pages 000001-23).
(3.2) The Company’s Bylaws are incorporated by reference to by reference to Exhibit 99.1 to the Company’s Form 8-K filed February 9, 2012.
(4.1) The Indenture (and the Promissory note exhibited therewith) defining the rights of former shareholders who tendered Common Stock to the Company for its $2 per share, five- year, 6% debenture, is incorporated by reference to the filing of such documents with the Schedule TO filed with the SEC, on June 7, 2000 (SEC file number reference 005-37409).
(10.1)
Amended and Restated Employment Agreements of 1994, with David Edell and Ira Berman and the Company are incorporated by reference to the Company’s Form 10-K/A filed April 5, 1995 (SEC file number reference 000-12723). *
(10.2)
The February 1999 Amendments to the Amended and Restated Employment Agreements of David Edell and Ira Berman (1994) are incorporated by reference to the Company’s Form 10-K filed February 26, 1999 (SEC file number reference 000-12723) (Exhibit pages 00001-00002). *
(10.3)
License Agreement made February 12, 1986 with Alleghany Pharmacal Corporation is incorporated by reference to the Company’s Form 10-K/A filed April 5, 1995 (SEC file number reference 001-12723).
(10.4)
The Company’s 2005 Amended and Restated Stock Option Plan is incorporated by reference to its 2005 Proxy Statement (Exhibit A) filed May 2, 2005 (SEC file number reference 001-31643). *
(10.5)
The Employment Agreement, dated March 21, 2011, by and between the Company and Stephen A. Heit is incorporated by reference to Exhibit 10.2 to the Company’s Form 8-K filed March 31, 2011. *
(10.6)
The Employment Agreement, dated March 21, 2011, by and between the Company and Drew Edell is incorporated by reference to Exhibit 10.3 to the Company’s Form 8-K filed March 31, 2011. *

43


(10.7)
The Change of Control Agreement, dated March 15, 2011, by and between the Company and Ira W. Berman is incorporated by reference to Exhibit 10.1 to the Company’s Form 8-K filed March 17, 2011. *
(10.8)
The Change of Control Agreement, dated March 15, 2011, by and between the Company and David Edell is incorporated by reference to Exhibit 10.2 to the Company’s Form 8-K filed March 17, 2011. *
(10.9)
Proposed Order of Settlement is incorporated by reference to Exhibit 10.1 to the Company’s Form 10-Q filed July 14, 2010.
(10.10)
Settlement and Mutual Release Agreement is incorporated by reference to Exhibit 10.1 to the Company’s Form 10-Q filed July 14, 2010.

(10.11)
Warrant to Purchase Common Stock, dated as of September 5, 2014, by and between CCA Industries, Inc. and Capital Preservation Solutions, LLC is incorporated by reference to Exhibit 10.1 to the Company’s Form 8-K/A filed February 5, 2015.

(10.12)
Loan and Security Agreement, dated as of September 5, 2014, by and between CCA Industries, Inc. and Capital Preservation Solutions, LLC. is incorporated by reference to Exhibit 10.1 to the Company’s Form 8-K filed September 11, 2014.

(10.13)
Separation Agreement, dated as of September 5, 2014, by and between CCA Industries, Inc. and David Edell is incorporated by reference to Exhibit 10.3 to the Company’s Form 8-K filed September 11, 2014.*

(10.14)
Separation Agreement, dated as of September 5, 2014, by and between CCA Industries, Inc. and Ira Berman is incorporated by reference to Exhibit 10.4 to the Company’s Form 8-K filed September 11, 2014.*

(10.15)
Services Outsourcing Agreement between CCA Industries, Inc. and Emerson Healthcare, LLC, dated as of January 20,2014 is incorporated by reference to Exhibit 10.1 to the Company’s Form 10-Q filed April 14, 2014.

(10.16)
Sales Representation Agreement between CCA Industries, Inc. and S. Emerson Group, Inc., dated as of January 20, 2014 is incorporated by reference to Exhibit 10.2 to the Company’s Form 10-Q filed April 14, 2014.
 
(11.00)
Statement re Per Share Earnings (included in Item 15, Financial Statements).

(31.1)
Certification of Chief Executive Officer pursuant to Rule 13a-14(a) included herein.
(31.2)
Certification of Chief Financial Officer pursuant to Rule 13a-14(a) included herein.
(32.1)
Certification of Chief Executive Officer pursuant to 18 U.S.C. 1350 included herein.
(32.2)
Certification of Chief Financial Officer pursuant to 18 U.S.C. 1350 included herein.

44


(101.Def)
Definition Linkbase Document †
(101.Pre)
Presentation Linkbase Document †
(101.Lab)
Labels Linkbase Document †
(101.Cal)  Calculation Linkbase Document †
(101.Sch)  Schema Document †
(101.Ins)  Instance Document †
*
Management contract and compensatory plan or arrangement.
Shareholders may obtain (without charge) a copy of this Annual Report on Form 10-K (including the financial statements and financial statement schedules) and a copy of any exhibit not filed herewith (upon payment of a fee limited to our reasonable expenses in furnishing such exhibit) by writing to CCA Industries, Inc., 200 Murray Hill Parkway, East Rutherford, New Jersey 07073. The Company also makes the reports it files to be available in the Investor Relations section of its website (http://www.ccaindustries.com). Moreover, the public may read and copy any materials we file with the SEC (including the exhibits thereto) at the SEC’s Public Reference Room at 100 F Street, NE, Washington, DC 20549. You may obtain information on the operation of the Public Reference Room by calling the SEC at 1-800-SEC-0330. In addition, the SEC maintains an Internet site that contains reports, proxy and information statements, and other information regarding issuers that file electronically with the SEC (http://www.sec.gov).


45


SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this Annual Report to be signed on its behalf by the undersigned thereunto duly authorized.
 
 
 
 
CCA INDUSTRIES, INC.
 
 
By:
 
/s/ RICHARD KORNHAUSER
 
 
RICHARD KORNHAUSER, Chief Executive Officer and President
 
 
Date:
 
March 2, 2015
Pursuant to the requirements of the Securities Exchange Act of 1934, this Annual Report has been signed below by the following persons on behalf of the Registrant and in the capacities and on the dates indicated.
 
 
 
 
 
 
Signature
 
Title
 
Date
/s/ RICHARD KORNHAUSER
 
Director, Chief Executive Officer and President
 
March 2, 2015
RICHARD KORNHAUSER
 
 
 
 
 
 
 
 
 
/s/ STEPHEN A. HEIT
 
Director, Chief Financial Officer and Chief Accounting Officer
 
March 2, 2015
STEPHEN A. HEIT
 
 
 
 
 
 
 
 
/s/ STANLEY KREITMAN
 
Chairman of the Board of Directors
 
March 2, 2015
STANLEY KREITMAN
 
 
 
 
 
 
 
 
/s/ JOSEPHINE BELLI
 
Director
 
March 2, 2015
JOSEPHINE BELLI
 
 
 
 
 
 
 
 
/s/ ROBERT LAGE
 
Director
 
March 2, 2015
ROBERT LAGE
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 




46





CCA INDUSTRIES, INC. AND SUBSIDIARIES
CONSOLIDATED FINANCIAL STATEMENTS
NOVEMBER 30, 2014 AND 2013

C O N T E N T S
 



47



Report of Independent Registered Public Accounting Firm

Board of Directors and Shareholders
CCA Industries, Inc.
East Rutherford, New Jersey
We have audited the accompanying consolidated balance sheets of CCA Industries, Inc. and Subsidiaries as of November 30, 2014 and 2013 and the related consolidated statements of operations, comprehensive (loss) income, shareholders’ equity, and cash flows for each of the three years in the period ended November 30, 2014. In connection with our audits of the financial statements, we have also audited the financial statement schedule listed in the accompanying index. These financial statements and schedule are the responsibility of the Company’s management. Our responsibility is to express an opinion on these financial statements and schedules based on our audits.
We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. Our audits included consideration of internal control over financial reporting as a basis for designing audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion. An audit also includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements, assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation of the financial statements and schedules. We believe that our audits provide a reasonable basis for our opinion.
In our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the financial position of CCA Industries, Inc. and Subsidiaries at November 30, 2014 and 2013, and the results of its operations and its cash flows for each of the three years in the period ended November 30, 2014, in conformity with accounting principles generally accepted in the United States of America.
Also, in our opinion, the financial statement schedule, when considered in relation to the basic consolidated financial statements taken as a whole, present fairly, in all material respects, the information set forth therein.



/s/ BDO USA, LLP
Woodbridge, New Jersey
March 2, 2015





48


Part I - FINANCIAL INFORMATION
ITEM 1. - FINANCIAL STATEMENTS
CCA INDUSTRIES, INC. AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS
 
 
November 30,
2014
 
November 30,
2013
ASSETS
 
 
 
 
Current assets:
 
 
 
 
Cash & cash equivalents
 
$
241,621

 
$
3,199,020

Short term investments & marketable securities
 

 
1,112,440

Accounts receivable, net of allowances of $2,967,668 and $1,081,278, respectively
 
2,248,301

 
5,473,452

Inventories, net of reserve for inventory obsolescence of $992,296 and $3,030,306, respectively
 
5,181,490

 
8,607,567

Prepaid expenses and sundry receivables
 
631,204

 
424,626

Prepaid and refundable income taxes
 
453,598

 
678,889

Deferred income taxes
 
2,883,285

 
2,668,747

Total Current Assets
 
11,639,499

 
22,164,741

 
 
 
 
 
Property and equipment, net of accumulated depreciation
 
1,108,600

 
1,489,799

Intangible assets, net of accumulated amortization
 
654,840

 
762,193

Deferred financing fees, net of accumulated amortization
 
1,341,458

 

Deferred income taxes
 
6,988,195

 
1,921,016

Other
 

 
8,000

Total Assets
 
$
21,732,592

 
$
26,345,749

 
 
 
 
 
LIABILITIES AND CAPITAL
 
 
 
 
Current Liabilities:
 
 
 
 
Accounts payable & accrued liabilities
 
$
10,731,031

 
$
9,246,072

Capitalized lease obligations - current portion
 
7,642

 
7,116

Total Current Liabilities
 
10,738,673

 
9,253,188

 
 
 
 
 
Line of credit - related party
 
600,000

 

Term loan - related party
 
805,813

 

Capitalized lease obligations
 
22,152

 
30,195

Total Liabilities
 
12,166,638

 
9,283,383

 
 
 
 
 
Shareholders' Equity:
 


 


Preferred stock, $1.00 par, authorized 20,000,000 none issued
 

 

Common stock, $.01 par, authorized 15,000,000 shares, issued and outstanding 6,038,982 and 6,038,982 shares, respectively
 
60,390

 
60,390

Class A common stock, $.01 par, authorized 5,000,000 shares, issued and outstanding 967,702 and 967,702 shares, respectively
 
9,677

 
9,677

Additional paid-in capital
 
3,814,484

 
2,329,049

Retained earnings
 
5,681,403

 
14,480,872

Unrealized gains on marketable securities
 

 
182,378

Total Shareholders' Equity
 
9,565,954

 
17,062,366

Total Liabilities and Shareholders' Equity
 
$
21,732,592

 
$
26,345,749

See Notes to Consolidated Financial Statements.

49


CCA INDUSTRIES, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF OPERATIONS

 
 
 
 
Years Ended November 30,
 
 
 
2014
 
2013
 
2012
Revenues:
 
 
 
 
 
 
 
Sales of health and beauty aid products - net
 
 
$
30,120,299

 
$
28,763,369

 
$
32,340,314

Other income
 
 
458,246

 
63,794

 
606,653

Total Revenues
 
 
30,578,545

 
28,827,163

 
32,946,967

Costs and Expenses:
 
 
 
 
 
 
 
Cost of sales
 
 
13,630,226

 
12,302,356

 
13,460,783

Selling, general and administrative expenses
 
 
11,794,603

 
18,345,284

 
19,442,552

Advertising, cooperative and promotional expenses
 
 
6,155,051

 
2,921,199

 
3,908,329

Research and development
 
 
458,984

 
741,694

 
769,637

Bad debt (recovery) expense
 
 
(24,721
)
 
55,204

 
(26,851
)
Interest expense - related party
 
 
314,213

 

 

Interest expense
 
 
22,259

 
2,249

 
299

Total Costs and Expenses
 
 
32,350,615

 
34,367,986

 
37,554,749

Restructuring Cost
 
 
2,738,570

 

 

Total Costs and Expenses
 
 
35,089,185

 
34,367,986

 
37,554,749

(Loss) Income before (Benefit from) Provision for Income Taxes
 
 
(4,510,640
)
 
(5,540,823
)
 
(4,607,782
)
(Benefit from) Provision for Income Taxes
 
 
(1,707,212
)
 
(2,029,541
)
 
(1,542,312
)
(Loss) Income from Continuing Operations
 
 
(2,803,428
)
 
(3,511,282
)
 
(3,065,470
)
Discontinued Operations
 
 
 
 
 
 
 
(Loss) Income from operations of discontinued brands
 
 
(9,647,472
)
 
(4,232,159
)
 
5,551,764

(Benefit from) Provision for Income Taxes
 
 
(3,651,431
)
 
(1,550,193
)
 
2,020,842

(Loss) Income from Discontinued Operations
 
 
(5,996,041
)
 
(2,681,966
)
 
3,530,922

Net (loss) Income
 
 
$
(8,799,469
)
 
$
(6,193,248
)
 
$
465,452

 
 
 
 
 
 
 
 
(Loss) Earning per Share:
 
 
 
 
 
 
 
    Basic
 
 
 
 
 
 
 
Continuing Operations
 
 
$
(0.40
)
 
$
(0.50
)
 
$
(0.43
)
Discontinued Operations
 
 
$
(0.86
)
 
$
(0.38
)
 
$
0.50

Total (loss) earnings per share
 
 
$
(1.26
)
 
$
(0.88
)
 
$
0.07

 
 
 
 
 
 
 
 
(Loss) Earning per Share:
 
 
 
 
 
 
 
    Diluted
 
 
 
 
 
 
 
Continuing Operations
 
 
$
(0.40
)
 
$
(0.50
)
 
$
(0.43
)
Discontinued Operations
 
 
$
(0.86
)
 
$
(0.38
)
 
$
0.50

Total (loss) earnings per share
 
 
$
(1.26
)
 
$
(0.88
)
 
$
0.07


 



 


 


Weighted Average Shares Outstanding:
 
 
 
 
 
 
 
Basic
 
 
7,006,684

 
7,037,694

 
7,054,442

Diluted
 
 
7,006,684

 
7,037,694

 
7,054,442

See Notes to Consolidated Financial Statements.


50


CCA INDUSTRIES, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF COMPREHENSIVE (LOSS) INCOME

 
 
 
Years Ended November 30,
 
 
2014
 
2013
 
2012
(Loss) from Continuing Operations
 
$
(2,803,428
)
 
$
(3,511,282
)